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Fear extinction learning is a highly adaptive process that involves the integrity of 
frontolimbic circuitry. Its disruption has been associated with emotional dysregulation in 
stress and anxiety disorders. The most common behavioral approach to treating stress and 
anxiety disorders is based on the principles of fear extinction learning, that of exposure 
therapy. Many  individuals  don’t  respond  well  to  this  therapeutic  approach, however, and 
why some individuals respond favorably to exposure-based therapies, and others don’t, is 
not well understood. This thesis seeks to consider how developmental and individual 
differences influence the capacity to regulate fear, as well as to test a behavioral method 
that leads to enhanced fear regulation (i.e., attenuation of fear memory).  Chapter 1 
provides an overview of the relevant humans and rodent literatures on individual and 
developmental differences in cued-fear regulation. Chapter 2 presents the first evidence 
for adolescent-specific diminished cued-fear extinction learning in humans, paralleling 
results previously observed only in rodents. In Chapter 3, a common single nucleotide 
polymorphism in fatty acid amide hydrolase  (FAAH), encoding an enzyme that plays an 
important role in the endocannabinoid system, is highlighted for its role in altering cued-
fear extinction learning. Chapter 4 tests a novel behavioral method for enhancing cued-
fear regulation based on the principles of memory reconsolidation in adolescent and adult 
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humans. Collectively, these studies point to markers that could potentially be used to 
identify patients for whom exposure therapy may not be effective and suggests an 
alternative approach that could lead to more efficacious treatments for these individuals.  
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Chapter 1 
The development and enhancement of fear regulation: an introduction 
 
Learning the relationship between threatening events and the cues that predict the 
onset of those events is an adaptive process that allows an individual to anticipate and 
minimize exposure to danger (Ohman and Mineka, 2001). Fear acquisition, the capacity 
to learn information about cues predictive of the onset of danger, is crucial to an 
individual’s survival. By learning to identify cues that signal imminent danger, an 
individual can act on the presence of such cues to initiate a defensive response.  
However, the relationship between cues and consequences often changes over time. Thus 
it is important for an individual to regulate cue-driven fear responding when the 
predictive value of a cue changes from danger to safety. This can be accomplished 
through fear extinction learning, a context sensitive process in which repeated 
presentations of a previously conditioned threat stimulus, unpaired with an aversive 
outcome, leads to a decrease in fear responding to that stimulus. Evolutionarily preserved 
through time and across biological species, fear acquisition and fear extinction learning 
processes provide an individual with the flexibility to survive and thrive in a constantly 
changing environment. 
 
  Fear learning processes have been the subject of intense neuroscientific scrutiny 
in recent years, as substantial evidence suggests that when these processes become 
dysregulated, this can lead to the emergence of psychopathology. Maladaptive fear 
responding lies at the root of numerous psychiatric disorders, such as stress and anxiety 
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disorders and post-traumatic stress disorder (PTSD). The personal and societal costs of 
these disorders are immense. Anxiety disorders affect about 40 million American adults 
in a given year (Kessler et al., 2005), creating significant negative impact on quality of 
life for victims, as well as an enormous economic burden of more than $35 billion spent 
annually on treatment and indirect costs of over $4 billion per year in lost productivity 
(Greenberg et al., 1999).   
The most common evidence-based behavioral treatment of anxiety disorders is 
cognitive behavioral therapy (CBT) (Rothbaum and Davis, 2003). Exposure-based CBT 
is based on principles of fear extinction learning and involves identification of what 
triggers the anxiety followed by systematic desensitization (repeated exposure) to that 
trigger in the absence of threat (Myers & Davis et al., 2002; LeDoux, 2000). 
Unfortunately, individuals who show diminished fear extinction learning may not 
respond well to exposure-based therapy, with only a little over 50% of individuals with 
clinical anxiety responding positively to exposure-based CBT (Walkup et al., 2008). 
However, the individual differences driving this variability in treatment response have 
not been well characterized. Furthermore, there exists the paradoxical situation in which 
the most common behavioral treatment approach for anxiety and stress-related disorders 
(exposure-based CBT) is built on the same learning process that mediates these 
individual’s   vulnerability   to   psychopathology   in   the   first   place (diminished fear 
extinction learning). Therefore, this dissertation is focused around three core goals: (1) 
identify specific developmental and individual difference factors that impact fear 
regulatory capacity; (2) elucidate the neural substrates underlying these effects, through 
examination and synthesis of human and animal studies, and (3) leverage this information 
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to devise and test new methods of enhancing fear regulatory capacity that could lead to 
novel clinical approaches for individuals who may not respond well to exposure therapy.   
 
In this introductory chapter, I will begin by providing some background on fear 
acquisition and extinction learning and discuss the core neural circuitry. I will then 
discuss the developmental trajectory of this circuit and present evidence that fear 
extinction learning is specifically diminished during the developmental stage of 
adolescence. I will next present evidence pointing to specific genetic factors (variants of 
the genes BDNF and FAAH) that play a role in fear regulation.  I will outline a neural 
substrate for diminished fear regulation common across the causal factors of age, 
experience and genetic profile; that is, immature functional integrity in a neural circuit 
consisting primarily of the prefrontal cortex and the amygdala.  Finally, I will focus on 
the clinical implications of diminished fear extinction learning and introduce alternatives 
to exposure-based methods of fear regulation, including a method based on the principles 
of memory reconsolidation that may bypass frontal regulation of fear and inform 
optimized clinical treatments for individuals with pathological anxiety who  don’t  respond  
well to exposure therapy.  
 
Fear Learning: an introduction 
 
Fear learning is an adaptive process that allows an organism to respond 
appropriately to cues or contexts that predict danger.  Behavioral paradigms based on the 
principles of classical conditioning have become the de facto standard for studying fear 
learning in animals and humans. Classical conditioning is a process based on Pavlovian 
learning principles in which a neutral stimulus is paired with a salient stimulus (Pavlov 
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and Anrep, 1927). During fear conditioning, a conditioned stimulus (the cue) is 
repeatedly paired with an aversive event (the unconditioned stimulus), such that the 
presentation of the cue alone comes to elicit a fear response, indicating the acquisition of 
a conditioned fear response (LeDoux, 2003). Once an associative link between the cue 
and aversive stimulus is formed and consolidated, it becomes a stable long-term memory. 
 
After a cue is no longer predictive of the onset of danger, however, it is 
maladaptive to respond as if it is still a threat. Typically a conditioned fear response can 
be reduced by extinction. During extinction, the cue is repeatedly presented by itself and 
fear expression decreases, as the animal learns that it no longer reliably predicts the 
aversive stimulus (Mackintosh 1974). Early models of fear extinction learning posited 
that extinction involved the unlearning of associations between a cue and an aversive 
stimulus (Rescorla and Wagner, 1972). However, it is now accepted that extinction 
reflects learning of a new memory trace that competes with the original fear memory for 
expression (Bouton 2004; Myers and Davis, 2002). If the extinction memory is strong 
enough and can be successfully retrieved, fear expression can be suppressed.  Substantial 
evidence shows, however, that while extinction learning can reduce the expression of 
conditioned fear, extinguished fear may return under a number of different circumstances 
including the simple passage of time (spontaneous recovery), exposure to an aversive 
stimulus or stressor (reinstatement) or exposure to a threat cue in a novel context 
(renewal) (Bouton 2004; Myers and Davis, 2002). In adaptive terms, this computes 
logically as the predictive value of an extinguished threat cue might become unclear 
under these conditions, and the penalty for failure to appropriately respond to a threat cue 
could be injury or death. The return of extinguished fear is therefore not categorically 
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maladaptive. However, when fear regulatory capacity is diminished an individual may 
respond repeatedly to cues once predictive of danger, even though danger is no longer 
present. Persistent fear responding to a safety cue is maladaptive and can lead to 
pathological states of anxiety. 
 
The neural circuitry of fear acquisition and extinction learning 
 
 
Substantial research in animals and humans has characterized the neural 
mechanisms underlying fear acquisition and fear extinction learning (Figure 1.1). The 
amygdala, a structure in the medial temporal lobe, is functionally segregated into 
subnuclei that play distinct roles in fear acquisition and expression (LeDoux 2007).  
During fear learning sensory thalamic inputs converge on the lateral amygdala (LA) 
(Quirk et al., 1995; Collins and Pare, 2000) driving fear expression through the central 
nucleus (CE) of the amygdala downstream toward output systems that mediate autonomic 
responses (Maren 2001). Learning has occurred when the conditioned stimulus alone is 
able to initiate activity in the LA and elicit a fear response, which prior to conditioning 
would have been elicited only by the unconditioned stimulus.  The hippocampus also 
plays a significant role in expression of fear memories that go beyond this dissertation.  
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The ventral medial prefrontal cortex (vmPFC) is critical for mediating fear 
expression and extinction (Quirk and Mueller, 2008; Phelps et al., 2004). Two distinct 
subregions of the rodent vmPFC, the prelimbic and infralimbic cortices, play specific 
functional roles in the expression and inhibition of fear, respectively. (Santini et al., 2008; 
Sierra-Mercado et al., 2011; Sotres-Bayon and Quirk, 2010). The prelimbic cortex (PL) 
has been implicated in the expression of fear via bilateral projections to and from the 
amygdala (Milad and Quirk, 2012). The PL receives transient inputs signaling the 
presence of threat from the amygdala and transforms these signals into sustained firing 
via downward projections to the CE (Sotres-Bayon and Quirk, 2010) and toward output 
Figure 1.1 Cued-Fear Circuitry. A simplified diagram of the neural circuitry 
underlying regulation of threat-related cues in rodents. Abbreviations: IL, infralimbic 
prefrontal cortex; PL, prelimbic prefrontal cortex; BA, basal amygdala; LA, lateral 
amygdala; CE, central amygdala; ITC, intercalated cells; vmPFC, ventromedial 
prefrontal cortex. Human regions homologous to the rodent PL and IL are dACC and 
vmPFC, respectively (from Johnson & Casey, 2015a). 
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systems that generate fear responses. The infralimbic cortex (IL) plays a contrasting role 
in the storage and recall of extinction memory (Quirk and Mueller, 2008). The LA and 
basal nucleus (BA) of the amygdala excite cells in the IL in response to safety signals 
(Repa 2001). Cells in the IL then modulate fear expression through projections to 
inhibitory (intercalated) cells in the amygdala, that in turn block activity in the CE, 
suppress outputs to downstream targets and blunt fear expression and related autonomic 
activity (Milad and Quirk, 2012). Thus, the vmPFC does not simply play an inhibitory 
role in fear regulation but rather regulates low and high fear states through subnetworks 
defined by bilateral projections between distinct regions of the vmPFC and functionally 
specific nuclei in the amygdala (Sotres-Bayon and Quirk, 2012).  
 
Many studies have shown that fear circuitry is highly conserved across species, 
suggesting similar neural mechanisms underlie fear learning and extinction in both mice 
and humans (Soliman et al., 2010; Milad et al., 2007a; Gottfried and Dolan, 2004). 
Technical limitations make it challenging to precisely delineate regions homologous to 
rodent infralimbic and prelimbic cortex in the human brain (Milad and Quirk 2012). 
However, the dorsal anterior cingulate cortex (dACC) has been associated with 
expression of conditioned fear in humans and has been proposed as the human 
homologue of the rodent prelimbic cortex (Milad et al., 2007a). This is supported by 
fMRI BOLD data that has shown dACC activity increases with expression of conditioned 
(Milad et al., 2007a) and unconditioned fear (Dunsmoor et al., 2008). Numerous human 
studies have demonstrated the importance of the vmPFC in fear extinction learning, 
supporting this region as functionally and structurally homologous to the rodent 
infralimbic cortex. Functional imaging studies show that increased vmPFC activity is 
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associated with less fear expression during extinction learning (Phelps, 2004; Kalisch et 
al., 2006) and better recall of extinction memory (Milad et al., 2007b). MRI-based 
volumetric studies show that larger vmPFC volume is associated with greater fear 
extinction learning (Shin, et al 2006) and better retention of extinction memory (Milad et 
al., 2005).  
 
Together these studies demonstrate that while the amygdala plays a role in 
acquisition, storage and retrieval of fear memory, regulation of fear is dependent on 
bilateral connections between the amygdala and the vmPFC. Converging evidence has 
linked anxiety and anxiety-related disorder to impaired fronto-amygdala regulation. Trait 
anxiety has been associated with heightened amygdala activity during fear learning in 
human adults (Indovina et al., 2011), while individuals with increased trait anxiety show 
compromised fear extinction learning that appears to be driven by dysreguated 
interactions between frontal and amygdala regions (Indovina et al., 2011; Lissek et al., 
2005).  In clinical populations, PTSD patients have shown diminished prefrontal blood 
flow in PET studies  (Bremner et al., 1999; Semple et al, 1996), reduced vmPFC activity 
when recalling traumatic events (Shin et al., 1999) and impaired fear extinction learning 
(Milad et al., 2008). In sum, these data suggest diminished functional capacity in fronto-
amygdala circuitry may underlie deficits in fear extinction learning and could be a factor 
contributing to the onset of pathological fear and anxiety. 
 
Anxiety disorders peak during adolescence (Merikangas et al., 2010; Costello et 
al., 2005). These disorders often persist into adulthood and early onset is often predictive 
of the most severe and disabling forms of adult psychopathology (Andersen and Teicher, 
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2008; Kim-Cohen, et al., 2003). Adolescence is also a developmental stage during which 
functional immaturity of fronto-amygdala circuitry is observed with stronger connectivity 
between early-developing subcortical regions than in later-maturing prefrontal regions 
(Casey et al., 2008). Therefore, the PFC is less capable of sufficiently suppressing 
emotions and actions mediated by subcortical limbic structures during adolescence.  In 
the next section, I review studies that collectively describe how functional immaturity in 
prefrontal-amygdala connections may underlie adolescent-specific diminished fear 
extinction learning.  
 
Structural and functional changes in frontolmbic circuitry during adolescence 
 
 
There are regional structural and functional changes in brain circuitry during 
adolescence.  Nonhuman animal work and post mortem human studies show that synaptic 
pruning reaches adult numbers in sensorimotor cortices before the prefrontal regions 
(Bourgeois et al., 1994; Huttenlocher & Dabholkar 1997). These regional changes are 
paralleled by human developmental imaging studies that show peaks in cortical thickness 
and volume in sensorimotor cortices and subcortical regions before association cortices 
(Gogtay et al., 2004; Sowell et al., 1999, 2004; Mills et al., 2014). This pattern of 
development can result in a functional imbalance during adolescence characterized by 
high, subcortically-driven reactivity to emotional events and low capacity to regulate 
emotional responses to these events through prefrontal connections. Recent evidence 
(McCallum et al., 2010; Hare et al., 2008) suggests that immature top down ventromedial 
(infralimbic) prefrontal projections to the amygdala during adolescence may lead to 
diminished fear extinction learning.     
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An example of functionally altered frontolimbic activity during adolescence 
comes from a study that examined developmental changes in fMRI BOLD signal to 
threat-related cues (fearful faces) (Figure 1.2A). This study demonstrated heightened   
amygdala activity to threat cues in adolescents relative to both children and adults (Hare 
et al., 2008; Figure 1.2B), consistent with other work showing that adolescents exhibit 
greater amygdala responses to emotional pictures than adults (Guyer et al., 2008; Monk 
et al., 2003). 
 
 
 
 
 
 
 
In this study, threat cues generated behavioral inhibition, as measured by 
increased time to respond to threat relative to non-threat cues.  Threat-related slowing in 
response latencies corresponded to greater amygdala and decreased vmPFC activity 
(Figure 1.2C). This inverse pattern between the vmPFC and amygdala is consistent with 
Figure 1.2. Adolescent-specific differences in threat reactivity and regulation. 
(A) Participants were instructed to either press or not press a button in response to 
neutral or angry faces. (B) Adolescents show greater amygdala reactivity to threat cues 
(angry faces) compared to children and adults.  (C) Cortical and subcortical neural 
regions associated with reaction time for fear targets. Region of left amygdala showed 
positive correlation with reaction time (top panel). Region of vPFC showed negative 
correlation with reaction time (bottom panel) (from Hare et al., 2008).  
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the role of the prefrontal cortex in modulating and regulating the fear response via 
projections to inhibitory cells (intercalated cells) in the amygdala that in turn inhibit 
central nucleus output that dampens the fear response.  To further constrain the 
interpretation of these findings, the researchers examined changes in amygdala activity as 
a function of time and to what extent habituation of the amygdala response over time was 
correlated with vmPFC activity.  Greater habituation in the amygdala was associated with 
greater connectivity between vmPFC and amygdala, with less habituation in the 
amygdala response correlating with higher self-reported trait anxiety. These latter 
findings are consistent with studies showing that fear regulatory circuitry is functionally 
compromised in anxious individuals (Kim and Whalen, 2009). While this study provides 
support consistent with the hypothesis of diminished functional capacity of prefrontal 
regions to inhibit amygdala responses to threat-related cues, there are not as of yet any 
published studies that have directly tested this idea using associative (Pavlovian) learning 
paradigms in adolescent humans.   For insight, we turn to human behavioral studies and 
rodent behavioral and neurobiological evidence that suggest adolescent-specific changes 
in fear regulation are mediated by a functional imbalance between prefrontal inhibitory 
regions and subcortical activity that drives fear expression. 
 
 
Fear regulation across development 
 
 
Although there is a large body of research examining fear extinction learning in 
adults, there is a surprising scarcity of research pertaining to adolescents. In one of the 
first rodent studies to directly test adolescent fear extinction learning, Kim and 
Richardson (2011) compared the behavior of pre-adolescent (p28), adolescent (p35) and 
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adult (p70) rats in a Pavlovian conditioning task. Although adolescent rodents showed 
within-session extinction equivalent to young adults and pre-adolescents, they showed 
attenuated extinction retention (enhanced return of fear 24 hours after extinction). In 
other words, despite no difference in attenuating fear during extinction, adolescents 
showed a significant return of fear later.  This study also demonstrated insufficient 
recruitment of the infralimbic cortex during extinction in adolescent compared to adult 
and preadolescent rodents.  
 
Pattwell et al. (2012a) have recently shown diminished within- and between-
session extinction learning in adolescent mice. Adolescent mice (p29) showed increased 
freezing at various test points over multiple days of extinction training compared to both 
adults (p70) and pre-adolescents (p23). This pattern was paralleled by diminished 
synaptic plasticity in infralimbic cortex of the adolescent mice compared to the pre-
adolescents and adults.  
 
To date, there have been very few studies examining fear conditioning and 
extinction learning in human adolescents. In one study, Haddad and colleagues (2011) 
presented teens with photographs of neutral faces paired with a negative event (angry 
face plus a critical comment), a positive event (happy face plus a compliment) or neutral 
event (neutral face plus a neutral comment). After each phase of the experiment, 
participants   rated  each  stimulus   for  “scariness.”  Participants   rated   the   faces  paired  with  
negative outcomes as significantly more scary than those paired with positive or neutral 
outcomes after acquisition and extinction. Although this study demonstrated that 
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there were no other age groups to which to compare the findings. Adolescent-specific 
diminished fear extinction learning ideally requires an adult and/or child group for 
comparison. In chapters 2 and 4, I will present data from two studies that contribute to 
filling this gap in the developmental fear learning literature, demonstrating diminished 
fear extinction learning in human adolescents compared to children and adults.  
 
Genetic influences on fear regulatory processes 
 
The general properties of fear learning systems and underlying neural substrates 
have been relatively well characterized over the past several decades (Phelps et al., 2004). 
However, factors that underlie individual variability in fear regulation are less well 
understood. While the developmental effects on fear extinction learning described in the 
aforementioned studies (Pattwell et al., 2012a; Johnson & Casey, 2015b) are robust on a 
population level, variability within both the adolescent and adult human samples 
highlight the importance of exploring factors that mediate individual differences in 
extinction learning processes. 
 
Emerging evidence suggests that fear learning is heritable (Hettema et al., 2003). 
As the neural circuitry underlying fear learning and regulation is quite complex, it is 
reasonable to assume that heritable influences on these processes involve multiple genes, 
each of which (or combinations thereof) possessing at least partially distinct functional 
roles. In this section I focus on two genes that play a central role in regulating fear 
extinction learning: brain derived neurotrophic factor (BDNF), implicated in multiple 
learning and memory processes, and fatty acid amid hydrolase (FAAH), an enzyme 
proposed to play a central role in anxiety-related behavior.  
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Brain-derived neurotrophin factor (BDNF) 
 
BDNF is a neurotrophin with a key role in mediating plasticity in the brain and 
regulating various learning and memory processes (Bramham and Messaoudi, 2005; 
Mahan et al., 2012), including fear extinction learning (Peters et al., 2010; Egan et al., 
2003). In humans, the BDNF gene contains a single-nucleotide polymorphism (SNP) at 
codon 66 that leads to a valine to methionine substitution (val66met). The presence of 
this SNP leads to decreased activity-dependent release of BDNF (Egan et al., 2003). One 
of the behavioral consequences of this SNP was highlighted by a study showing 
increased anxiety-like behavior in genetically-modified Val66Met mice (with a 
methionine substitution at codon 66) compared to wild types (Chen et al., 2006), with the 
Val66Met mice spending less time in the open arms of a T-maze.  
Because dysregulated fear expression is a fundamental component of anxiety-
related behavior, Soliman et al. (2010) conducted a parallel study in mice and humans to 
test whether BDNF might exert an influence on fear extinction learning and associated 
neurobiological substrates (Soliman et al., 2010). In both mice and humans, the Met 
allele carriers showed less extinction learning than non-Met allele carriers (Figure 1.3A, 
1.3B). Humans showed concordant alterations in fMRI BOLD activity in fear regulatory 
circuitry, with Met allele carriers showing less vmPFC and greater amygdala activity 
during extinction than non-Met allele carriers (Figures 1.3C, 1.3D). 
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Subsequent rodent studies have attributed this BDNF-mediated impairment in 
extinction learning to diminished synaptic plasticity in infralimbic cortex (Pattwell et al., 
2012b). Decreased capacity to extinguish fear memories can be rescued by infusion of 
BDNF into this same region (Peters et al., 2010).  
 
             These findings are concordant with studies that have linked BDNF genotype to 
increased stress reactivity underlying posttraumatic stress disorder (PTSD), a 
pathological condition characterized by impaired fear extinction learning. Met carriers 
have an increased risk for PTSD compared to non-Met allele carriers (Rakofsky et al., 
2012) with a 3-fold increase in carriers homozygous for the Met allele (Zhang et al., 
2014). Together these findings underscore the importance of neurotrophin factor in 
learning when cues of potential danger are no longer a threat. These findings further 
Figure 1.3 Altered extinction learning in mouse and human Met allele carriers. 
(A) Diminished extinction in mice with BDNF Val66Met as indexed by changes in 
freezing across extinction. (B) Similar effects were shown in human Met allele carriers, 
as measured by changes in skin conductance response (SCR) during extinction.             
(C) Human Met allele carriers showed less BOLD activity in the vmPFC during 
extinction. (D) Humans with BDNF Val66Met showed increased amygdala activity 
compared to val/val homozygotes. (from Soliman et al., 2010).   
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suggest that decreased available BDNF may play an important role in vulnerability to 
anxiety and stress-related disorders due to less capacity to regulate fears and emotions.  
 
Fatty Acid Amide Hydrolase (FAAH) 
 
               The endocannabinoid system has been implicated as playing a role in anxiety 
and stress-related processes and disorders (Hariri et al., 2009; O. Gunduz-Cinar et al., 
2013a). Anandomide (AEA), an endogenous cannabinoid (eCB) that modulates synaptic 
transmission through stimulation of the CB1 receptor, has been suggested to play a key 
role in this effect (O. Gunduz-Cinar et al., 2013a; O. Gunduz-Cinar et al., 2013b). Fatty 
acid amide hydrolase (FAAH) is a catabolic enzyme that controls levels of AEA 
signaling in the brain (Cravatt et al., 2001). In humans, a SNP exists in FAAH that leads 
to decreased levels of FAAH, elevated AEA and enhanced signaling activity at CB1 
receptors (Sipe et al., 2002; Sipe et al., 2010). Genetic or pharmacologic disruption of 
FAAH is associated with decreased anxiety-like behaviors (Kathuria et al., 2003; Moreira 
et al., 2008) and enhanced fear extinction learning (Gundaz-Cinar et al., 2013a; Kathuria 
et al., 2003: Chhatwal et al., 2005). However, the ability to characterize the effects of the 
FAAH variant in the brain has been limited, since the variant is only present in humans. 
In Chapter 4 I present evidence in support of a central role of FAAH for enhancing fear 
extinction learning in humans, along with supporting data from a knock-in mouse, 
enabling the demonstration of parallel molecular, circuit-level and behavioral phenotypes 
in humans and in the knock-in mice carrying this variant. This evidence suggests a 
central role for FAAH in mediating fear regulatory capacity. 
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Methods for enhancing extinction – pharmacological and behavioral 
 
Together, the literature suggests developmental time points, as well as genetic 
factors, that may reduce the efficacy of exposure therapy for specific individuals.  In 
these cases, alternative evidence-based treatments might be employed.  
 
Pharmacological interventions offer one alternative. A pharmacological approach 
most commonly involves conducting extinction training in conjunction with the 
administration of a pharmacologic agent designed to increase plasticity in the neural 
circuitry underlying extinction learning and memory. Several drugs have been shown to 
enhance fear regulation.  Administration of D-cycloserine (DCS) led to enhanced 
extinction retrieval in adolescent and adult rats (McCallum et al., 2010; Baker et al., 
2012). DCS has also been shown to decrease fear in humans, with one study showing that 
DCS administered before virtual reality exposure therapy for acrophobia led to decreased 
fear at a subsequent fear recovery test. (Ressler et al., 2004). On the contrary, DCS has  
failed to enhance within-session extinction or extinction retrieval in other human studies 
(Klumpers et al., 2012; Guastella et al., 2007). Serotonin selective reuptake inhibitors 
(SSRIs) such as fluoxetine and citalopram have proven effective in enhancing extinction, 
with studies showing that chronic administration of SSRIs in combination with extinction 
training prevented the return of fear in mice  (Karpova et al., 2011; Deschaux et al., 
2011). Recent studies have also explored the role of dopamine in the consolidation of 
extinction memories. Methylphenidate, the dopamine and norepinephrine reuptake 
inhibitor known commercially as Ritalin, has been shown to enhance contextual 
extinction learning when administered before and during extinction training in mice 
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(Abraham et al., 2012). Haaker et al. (2013) showed that systemic administration of L-
Dopa (the precursor of dopamine) after extinction led to a decrease in contextual renewal; 
that is, the context dependence of extinction learning was reduced, as were spontaneous 
recovery and reinstatement. All of the aforementioned drugs can be administered 
systemically and are approved for use in humans. It should be noted that no single 
neurobiological mechanism, neurotransmitter or receptor subtype is responsible for the 
pharmacologically-mediated enhancement of fear extinction, highlighting the large 
number of molecular entry points into the fear learning circuitry. Data from animal 
studies suggests additional pharmacological agents such as histone acetylation 
modulators (Lattal et a., 2007), fibroblast growth factor (Graham & Richardson 2009), 
neuropeptides (Lach and de Lima, 2013; Gutman et al., 2008; Verma et al., 2012) and M-
type potassium channel modulators (Santini & Porter 2010) can enhance regulation of 
fear, but these drugs have, as of yet, only been tested pre-clinically in animals. It is 
important to note that off-target effects diminish the attractiveness of a pharmacological 
approach, as systemic administration of many of these drugs can produce undesirable 
acute side effects, while chronic effects, particularly in the developing brain, are not well 
understood. Furthermore, its not known if the effects of these drugs to enhance fear 
regulation is long lasting. Nonetheless, a pharmacological approach may be net beneficial 
for some individuals, particularly for those   who   don’t   respond   well   to   non-
pharmacological treatments. It is also important to note that not all individuals will 
respond equally well to any given drug. Individual differences in the neurophysiological 
profile of the fear circuitry suggests that specific drugs for specific patients, administered 
singularly or in combination with other drugs, would be most likely to maximize positive 
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treatment outcomes for any given individual, assuming valid and reliable assessment of 
individual response profiles can be made.  
 
Rodent studies have demonstrated that adolescents can benefit from an increased 
number of exposure trials during extinction (McCallum et al., 2010). However, this 
approach may not be ideal for adolescents with anxiety disorders as it would require 
additional time and money and could lead to higher attrition rates and increased failure to 
complete treatment. One promising behavioral approach, described below and reported in 
Chapter 4 (Johnson & Casey, 2015b), is based on the principles of memory 
reconsolidation.  
 
Memory Reconsolidation: A possible temporal window during which fear memories 
can be altered? 
 
The traditional view of memory formation is that it involves a one-time 
consolidation process, after which a memory becomes stable and no longer prone to 
interference (Squire and Davis, 1981; McGaugh, 2000). Research has demonstrated that 
consolidation of a new long-term memory could be disrupted by blocking protein 
synthesis (Schafe et al., 1999) or pharmacological intervention (Pitman et al., 2002; 
Vaiva et al., 2003), but only if the intervention occurred shortly after training and not 
several hours later. This approach has limited clinical utility because it is difficult to get 
access to patients immediately following a traumatic event.  Therefore, an increasing 
amount of recent interest has been focused on reconsolidation as a temporal target for 
interfering with or attenuating fear memories.  
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The memory reconsolidation hypothesis suggests that every time a memory is 
retrieved it becomes unstable (Sara 2010) and dependent on de novo protein and RNA 
synthesis for restabilization (Dudai 2006; Nader et al., 2000). The plasticity induced by 
memory  retrieval  opens  up  a  “reconsolidation  window”  during  which  a  memory  becomes  
prone to disruption (Dudai, 2006). This plasticity has been demonstrated by findings in 
rats that showed fear memory erasure could be induced after post-retrieval intra-
amygdala infusion of protein synthesis inhibitors anisomycin  (Nader et al., 2000; 
Duvarci and Nader, 2004) and U0126 (Doyere et al., 2007), and NMDA receptor 
antagonist MK-801 (Lee et al., 2006). Unfortunately, these compounds are toxic and not 
safe for use in humans (Duvarci and Nader, 2004).  
 
Dębiec  and  LeDoux (2004) showed that intra-amygdala and systemic infusion of 
beta-adrenergic receptor blocker propanalol (non-toxic and safe in humans) could disrupt 
fear memory reconsolidation in rats.  This finding was recently extended to humans using 
systemic treatment (Kindt et al., 2009). In this study, participants who received 
propranolol prior to retrieval of a conditioned fear memory showed persistent attenuation 
of fear response on a subsequent fear recovery test (but see Schiller and Phelps, 2011). 
Another promising approach to attenuating fear memory during reconsolidation was 
recently tested by Graff et al (2014), with evidence suggesting epigenetic mechanisms 
can be targeted, in combination with extinction training, to permanently modify fear 
memories during reconsolidation in rodents.  Even if pharmacological or epigenetic 
approaches proved safe in humans and effective in disrupting reconsolidation, a 
behavioral procedure would still be preferable due to possible off-target effects, assuming 
similar effects could be obtained with behavioral methods.  
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Such a procedure was introduced by Monfils et al (2009) and has recently been 
tested in human adults (Schiller et al., 2010a). This methodology capitalizes on 
reconsolidation theory not by interfering with reconsolidation processes, but rather by 
using behaviorally induced interference (post-retrieval extinction) to introduce new 
information about the conditioned stimulus during reconsolidation, update the original 
memory trace and prevent the return of fear (Oyarzun et al., 2012; Agren et al., 2012, and 
Steinfurth et al., 2014 but also see Kindt and Soeter, 2013 and Golkar et al., 2012).   
 
This method involves activation of a fear memory by presentation of an isolated 
retrieval trial followed by an extinction session that takes place during the subsequent 
reconsolidation window. The precise temporal duration of this window is not precisely 
known but is thought to be from 10 minutes to up to at least an hour, but not more than 6 
hours after retrieval (Monfils et al., 2009). Schiller et al (2010a) designed two 
experiments to test whether behavioral extinction training during memory reconsolidation 
would lead to persistent attenuation of fear. In the first study, three groups of participants 
were differentially conditioned to acquire fear by pairing a colored square (the 
conditioned stimulus) with an aversive reinforcer (an electric shock) while another 
colored square was never paired with the electric shock (experimental day 1).  Twenty-
four hours later (experimental day 2), participants underwent an extinction session during 
which both conditioned stimuli were presented repeatedly unpaired with the electric 
shock. All participants showed significant fear extinction, as indexed by decreases in skin 
conductance response (SCR) to the conditioned stimulus. In two groups, the conditioned 
stimulus was reminded prior to extinction via a single presentation trial. One group 
received the reminder trial 10 minutes before extinction, while the other group received 
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the reminder trial 6 hours before extinction. The third group did not receive a reminder 
trial prior to extinction.  Another 24 hours later (experimental day 3), participants 
returned to test for spontaneous recovery of the conditioned fear response. Participants 
who   weren’t   reminded of the conditioned stimulus prior to extinction or who were 
reminded but extinguished outside of the reconsolidation window showed robust 
recovery of fear for the conditioned stimuli, but there was no spontaneous recovery of 
fear in participants for whom the CS+ was reactivated 10 minutes prior to extinction. 
Attenuation of conditioned fear was still present when participants returned for a fear 
recovery test one year later, demonstrating the persistence of this effect (Schiller et al., 
2010a).  
 
In a second study, a within-subject design was employed to control for the 
possibility of unintended group effects and allow for direct comparison of the return of 
fear with or without reconsolidation update.  Participants were conditioned to two 
different colored squares (conditioned stimuli) via partial reinforcement with electric 
shock, while a third square was never paired with the shock. Prior to extinction, one of 
the conditioned stimuli was reminded via a single presentation trial, while the other was 
not. Recovery of fear was elicited via four unsignaled presentations of the US prior to the 
fear recovery test (reinstatement), which has been demonstrated as a robust method to 
elicit the return of an extinguished fear memory (Bouton 2004). Participants only showed 
a reinstated fear response to the conditioned stimulus that was not reminded prior to 
extinction. These studies collectively support the notion that behavioral extinction during 
reconsolidation can lead to persistent attenuation of conditioned fear.    
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Evidence from rodents has shown that the neural mechanism of action for the 
reconsolidation of fear memories is a cascade of molecular events taking place in the 
lateral nucleus of the amygdala (Monfils et al., 2009; Nader et al., 2000; Duvarci and 
Nader, 2004; Debiec and LeDoux, 2004). Recent human imaging studies have reiterated 
this finding by demonstrating behavioral interference during reconsolidation led to 
persistently attenuated fear at a subsequent recovery test, independent of PFC 
involvement (Agren et al., 2012), as well as showing that if fear extinction occurred 
during reconsolidation, decreases in fear response were not mediated by prefrontal 
activity (Schiller et al., 2013). These findings support the notion that reconsolidation 
update is a pre-frontally independent method of fear regulation.  This makes it a 
potentially attractive alternative to extinction for adolescents, a developmental group 
characterized by protracted development of prefrontal regions upon which successful 
extinction is dependent. It may also be helpful for individuals with genetic profiles that 
cause them to respond poorly to exposure-based therapies that presumably rely on 
prefrontally-mediated regulation of fear. We tested this method in adolescent humans and 
the results of this experiment are discussed in Chapter 4 (Johnson & Casey, 2015b).  
 
The current thesis 
 
            The goal of this thesis is to characterize developmental and individual differences 
in fear extinction learning in humans and to test methods to enhance fear regulation in 
these populations. The format for the current thesis is as follows: Chapter 1, 
“Introduction”,   provides background information necessary to set the stage for 
eludicating the role of fear extinction learning in the etiology and treatment of stress and 
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anxiety disorders. I lay the groundwork for an exploration of the roles that developmental 
stage and genetic profile play in mediating these regulatory processes, as well as 
introduce possible alternatives to extinction learning that could lead to enhanced fear 
regulation1.  Chapter  2,  “Diminished fear extinction learning in adolescents”,   (Pattwell, 
Duhoux, Hartley, Johnson, et al., PNAS, 109(40), 16318-16323) provides evidence from 
humans that the developmental stage of adolescence is a time during which fear 
extinction learning is diminished.  Chapter   3,   “Parallel effects of FAHH in fear 
regulation”, (Divencha, Drysdale, Hartley, Johnson 2 , et al., 2015) demonstrates that 
variation in the FAAH gene mediates the rate of fear extinction learning in human adults. 
Chapter  4,  “Fear regulation during adolescence: a matter of timing” (Johnson & Casey, 
2015b), demonstrates that a method based on the principles of memory reconsolidation, 
reconsolidation update, can be utilized to block the recovery of fear in adolescent 
humans. Chapter 5,   “Conclusions”,   synthesizes the findings presented in Chapters 2 
through 4, as well as discussing limitations, clinical implications and future directions.  
 
 
 
 
 
 
 
 
 
 
                                                         1 Parts of this chapter originally appeared in Johnson & Casey (2015a), Easy to remember, difficult to 
forget: The development of fear regulation.  Developmental Cognitive Neuroscience, 11, 42-55 2 Co first author   
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Chapter 2 
 
 Altered fear learning across development in humans 
 
Introduction 
 
Fear learning is a highly adaptive, evolutionarily conserved process that allows 
one to respond appropriately to cues associated with danger. In the case of psychiatric 
disorders, however, fear may persist long after an environmental threat has passed. This 
unremitting and often debilitating form of fear is a core component of many anxiety 
disorders, including posttraumatic stress disorder (PTSD), and involves exaggerated and 
inappropriate fear responses. Existing treatments, such as exposure therapy, are based on 
principles of fear extinction, during which cues previously associated with threat are 
presented in the absence of the initial aversive event until cues are considered safe and 
fear responses are reduced. Extinction-based exposure therapies have the strongest 
empirical evidence for benefitting adult patients suffering from PTSD (Rothbaum et al., 
2003), yet a comparative lack of knowledge about the development of fear neural 
circuitry prohibits similarly successful treatment outcomes in children and adolescents 
(Liberman et al., 2006). Adolescence, in particular, is a developmental stage when the 
incidence of anxiety disorders peaks in humans (Monk et al., 2003; Kessler et al., 2005; 
Merikangas et al., 2011; Newman et al., 1996), and it is estimated that over 75% of adults 
with fear-related disorders met diagnostic criteria as children and adolescents (Pollack et 
al., 1996; Kim-Cohen et al., 2003). Because of insufficient or inaccurate diagnoses and a 
dearth of pediatric and adolescent specialized treatments, fewer than one in five children 
or adolescents are expected to receive treatment for their anxiety disorders (Merikangas 
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et al., 2010), leaving a vast number with inadequate or no treatment (Liberman et al., 
2006; Keller et al., 1992). The increased frequency of anxiety disorders in pediatric and 
adolescent populations highlights the importance of understanding neural mechanisms of 
fear regulation from a developmental perspective, as existing therapies directly rely upon 
principles of fear-extinction learning. Converging evidence from human and rodent 
studies suggests that insufficient top-down regulation of subcortical structures (Levesque 
et al., 2004; Galvan et al., 2006; Hare et al., 2008; Casey et al., 2010), such as the 
amygdala, may coincide with diminished prototypical extinction learning (Milad & 
Quirk, 2012), as well as ongoing fine-tuning of excitatory–inhibitory balance in the 
prefrontal cortex that may coincide with diminished prototypical extinction learning 
(Hensch et al., 2005). Because top-down prefrontal regulation has been postulated to 
mediate extinction learning and may determine the efficacy of exposure therapy often 
used as part of cognitive behavioral therapy, it is important to discern how changes in the 
development of prefrontal circuitry influences fear extinction. Studying the development 
of fear learning and memory in humans, while examining, in parallel, the underlying 
neural mechanisms in rodent models, may offer insights into optimizing treatment 
strategies for developing populations by clarifying when, during development, a 
particular intervention or treatment may be more or less effective. 
 
Methods 
 
 
Participants  
Eighty-three healthy volunteers, including 30 children (5–11 y old; 14 male, mean 
age = 8.8 y), 28 adolescents (12–17 y old; 15 male; mean age = 13.9 y), and 25 adults 
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(18–28 y old; 12 male, mean age = 22.8 y), completed the study. An additional 42 
participants (13 children, 16 adolescents, 13 adults), were excluded from analysis because 
they  either  didn’t  show  measurable  skin  conductance  response  (SCR)  (n  =  20,  5  children,  
10 adolescents, 5 adults), failed to differentiate between the threat and safety cues [i.e., 
no difference in mean galvanic skin response to conditioned stimulus (CS)+ compared 
with  CS−  in  any  run  of  the  acquisition  session  or  in  the  first  run  of  the  extinction  session]  
(n = 17, three children, six adolescents, eight adults) or requested to stop participating 
before the conclusion of the study (five children). In addition, the four youngest females 
in the adult cohort were excluded to balance the sex ratios within each group. Trait 
anxiety was assessed using the Spielberg State-Trait Anxiety Inventory trait subscale 
(STAI-T). Trait anxiety ratings were collected from all but three participants (one child, 
one adolescent, and one adult). Pubertal development was assessed through self-report or 
parent reports for two standardized scales (Petersen et al., 1988; Tanner, 1962), resulting 
in an averaged Tanner staging correspondence of Tanner stage 1 to preadolescence, 
Tanner stages 2, 3, and 4 to adolescence, and Tanner stage 5 to postadolescence. 
 
Experimental Design 
 
Participants underwent a partial-reinforcement discriminative fear-conditioning 
paradigm spanning 2 days (Figure 2.1A). Two colored squares were used as stimuli. On 
day 1, one square (CS+) was paired on 50% of the trials with an aversive sound 
[unconditioned stimulus (US)]. The other square was never paired with the aversive 
sound  (CS−).  The  color  of   the  CS+  and  CS−  was  counterbalanced  across  subjects.  The  
partial pairing of the US with the CS+ allowed us to analyze the response to the CS+ 
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independently of the response triggered by the tone. One day later, all participants 
underwent   extinction   training   wherein   the   CS+   and   CS−   were   presented   repeatedly  
without the US. The paradigm was adapted from one previously used (Soliman et al., 
2010). Participants were not informed about the goals of the study; they were told to 
attend to the stimuli, to press a key when each square appeared on the screen (to ensure 
attention), and that they may occasionally hear a loud noise. Each CS was presented for 3 
s each, with a 13-s intertrial interval (ITI). The duration of the ITI was set to ensure that 
SCR responses could return to baseline and allow responses to be decoupled between 
trials. On reinforced CS+US trials, the CS+ coterminated with the US. The conditioning 
session consisted of 12 CS+US, 12 nonreinforced   CS+,   and   24   CS−   trials.   Extinction  
consisted   of   24   CS−   and   24   nonreinforced   CS+   trials.   Stimuli   were   presented   in  
pseudorandomized order, avoiding consecutive CS+USs during the conditioning session 
and allowing no more than two consecutives squares of the same color in either session. 
Both the conditioning and extinction sessions were divided into three runs of 16 trials 
each, with each run lasting 4 min 26 s; a brief break occurred between each run. The 
auditory stimulus was a white noise combined with a 1,000-Hz tone, which was intensity 
tiered for smooth onset and offset. It was rated as aversive in an independent experiment 
(Levita et al., 2009). The sound was delivered in both ears, through headphones. Sound 
intensity was tested before each experiment using an audiometer, and subjects chose a 
sound level that was very unpleasant but not painful. The sound intensity level ranged 
from 85 dB to 95 dB (mean ± SD; 92.5 ± 2.9) in children, from 94.5 dB to 107 dB in 
adolescents (96.5 ± 2.4), and from 94 dB to 104 dB in adults (96.5 ± 2.4). The duration of 
the auditory stimulus was 1 second.  
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Physiological Measurement and Analysis 
 
Skin conductance response (SCR) was acquired using disposable snap electrodes 
pre-gelled with isotonic gel, which were attached to the distal phalanx of the second and 
third digits of the left hand. The signal was recorded and amplified using a skin 
conductance recording system  (MP35; Biopac) in combination with AcqKnowledge 
software (Biopac). E-prime software (Psychology Software Tools) was used to control 
the presentation of visual and auditory stimuli and send time markers to the skin 
conductance recording system for each context and stimulus onset/offset. The SCR was 
sampled at 200 Hz with a 1-HZ filter applied. SCR was analyzed manually. For each 
individual subject, data were smoothed. Measurable peaks were identified as the first 
SCR response that occurred within .5-4.5 s following stimulus onset as defined by the 
difference between trough and peak being equal to or greater than .02 uS 
(microsiemens)(Schiller et al., 2013). A zero value was added into the analysis when no 
peak was detected. SCR scores were square root-transformed to normalize the 
distribution   and   were   then   scaled   to   the   participant’s   largest   response   to the CS+US 
during acquisition to normalize responses across participants.  These SCR scores were 
averaged for each participant for each stimulus type separately. All SCR responses 
reported for acquisition reflect differences between responses to the CS+ and 
corresponding CS-. SCR responses reported for extinction reflect responses to the CS+ 
only.  
 
 
 
30  
Results 
 
Immature functional connectivity between the ventromedial prefrontal cortex 
(vmPFC) and amygdala in adolescents has previously been shown in tasks of emotion 
regulation (Hare et al., 2008). Therefore, we sought to investigate age-dependent 
differences in fear-extinction learning in humans, as cumulative evidence suggests a 
relationship between fear extinction learning capacity and functional connectivity 
between these same neural regions (Milad and Quirk, 2012). Using age delineations for 
children, adolescents, and adults, we assessed skin conductance response across 
development in humans to measure prototypical physiological fear responses during 
conditioned fear acquisition and fear memory extinction (Pattwell et al., 2011; Soliman et 
al., 2010; Laviola et al., 1999; Adriani et al., 1998; LeDoux 2000).  
 
A two-way ANOVA on skin conductance response during late acquisition (the 
last of three acquisition runs) with main factors of age group (children, adolescents, 
adults)  and  stimulus  type  [paired  conditioned  stimulus  (CS+)  or  unpaired  (CS−)  with  an  
aversive  noise]  showed  a  main  effect  of  stimulus  type  (CS+  >  CS−)  [F(1,  79)  =  10.786,  P  
= 0.002] and no Group x Stimulus type interaction [F(2, 79) = 0.032, P = 0.968], 
demonstrating that all subjects learned to discriminate between the threat cue and the 
safety cue (Figure 2.1).  
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Figure 2.1. Cued fear acquisition across development in humans. (A) There were no 
developmental differences in fear acquisition in the human subjects. 
 
Furthermore, there was no main effect of age group on responses to either 
stimulus  type  [CS+:  F(2,79)  =  0.581,  P  =  0.562;;  CS−:  F(2,  79)  =  0.655,  P  =  0.522]  or  the 
differential   acquisition  measure   [CS+  −  CS−:  F(2,   79)  =   0.021,  P  =   0.979]   during   late  
acquisition. Thus, any subsequent group effects in extinction learning are not related to 
differences in fear acquisition. In contrast, analysis of extinction indices revealed a main 
effect of age group for humans [F(2, 80) = 3.228, P = 0.038], such that adolescents 
showed attenuated fear-extinction learning compared with children [t(56) = 2.34, P = 
0.023] and a trend towards attenuated fear-extinction learning compared to adults [t(51) = 
1.802, P = 0.078] (Fig. 2.2B). This effect of age group on fear extinction was present 
when sex and trait anxiety are entered as covariates [F(2, 73) = 3.086, P = 0.052]. There 
was no significant difference in extinction learning between children and adults (P = 
0.701). 
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Figure 2.2. Cued extinction learning and spontaneous recovery across development 
in humans. (A) Behavioral paradigms for fear conditioning experiments in humans. (B) 
Analysis  of  extinction  indices  [(averaged  first  two  extinction  trials)  −  (averaged  last  two  
extinction trials)] reveals a main effect of age group for humans, such that adolescents 
display attenuated fear extinction learning compared with children and adults, (adolescent 
0.05916 ± 0.06904; children 0.25435 ± 0.04839; adults 0. 22510 ± 0.05931) 
 
 
Discussion 
 
Adolescence is a highly conserved developmental stage, both neurobehaviorally 
and physiologically, during which all mammals must meet evolutionary pressures 
associated with sexual emergence and transition from dependence on parents to 
independence (Spear 2004). Fear learning plays a critical adaptive role in this process as 
the adolescent leaves the relatively protected and stable family environment and explores 
a novel and highly variable outside environment. Defining the unique attributes of fear 
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acquisition and extinction during adolescence may have wide clinical implications, as the 
most common and validated treatment for anxiety disorders involves exposure-based 
therapy, which relies heavily on extinction principles for reevaluating existing 
contingencies (Rothbaum & Davis, 2003).  
 
Parallel studies in the rodent were conducted simultaneous to the human study 
presented here. Conservation of the behavioral demands associated with adolescence 
provides face and construct validity for translational studies of fear learning in this age 
group. The animal studies presented below in support of the human studies are 
particularly important because human experiments are limited in the extent to which the 
underlying molecular mechanisms can be probed. Fear learning processes are highly 
conserved across species and evolutionary time. This suggests that diminished fear 
learning might be observed in adolescents across species and that a neural mechanism 
common to both humans and rodents may underlie this age-specific behavioral 
phenotype. Pattwell et al (2012a) conducted parallel Pavlovian fear-learning experiments 
in preadolescent (P23), adolescent (P29), and adult (P70) mice to assess developmental 
differences in conditioned fear acquisition and extinction learning at ages comparable to 
human children, adolescents and adults (Spear 2000; McCallum et al., 2010) (Fig 2.2A). 
In these experiments, Pattwell et al. (2012) showed diminished extinction learning and 
retention of extinction memory in adolescent mice (P29) compared to younger (P23) and 
older mice (P70), as indexed by freezing, a pattern of results similar to that observed in 
the humans (Fig 2.1B). 
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Fig. 2.3. Cued extinction learning across development in mice. (A) Behavioral 
paradigms for fear conditioning experiments in mice. (B) A lack of extinction learning 
and retention of extinction memory in is observed in adolescent mice, as displayed by a 
significantly  decreased  differential  extinction  indices  [(Day  1,  Tone  1)  −  (Day  4,  Tone  5)]  
compared with older and younger ages, (P23 66.5% ± 2.75; P29 14.72% ± 4.79; P70 
35.17% ± 4.89). (C). Adolescent mice display attenuated extinction learning over the 
course of four days compared with preadolescent and older adult mice. From Pattwell et 
al., 2012a. 
 
Immunohistochemical and electrophysiological experiments showed that the 
mechanism underlying this age-specific difference in extinction learning is immature 
connectivity between infralimbic cortex and the amygdala (Pattwell et al., 2012a). Strong 
cross-species preservation of the neural circuitry implicated in fear-extinction learning is 
supported by human and nonhuman animal extinction studies, further bolstering the 
translational credibility of rodent experiments to explore mechanistic underpinnings that 
are otherwise precluded from experiments with human subjects (Soliman et al., 2010; 
Gottfried & Dolan 2004). 
 
Collectively, the human data presented in this chapter and mouse data from the 
Pattwell et al (2012a) studies have demonstrated attenuated extinction learning, at a 
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defined developmental stage, in both mice and humans. Through performing parallel 
human and mouse studies examining fear acquisition and extinction, it was possible to 
uncover similar developmental patterns in fear-extinction learning, lending credibility to 
the use of a developmental mouse-model system for examining human adolescent fear 
and anxiety. Confirming that similar developmental patterns in fear-extinction behavior 
exist for both mice and humans allows for the use of the mouse model system to probe 
underlying physiological mechanisms responsible for the attenuated fear-extinction 
learning observed in adolescence. Earlier studies have shown changes in intrinsic 
properties of the vmPFC neurons after fear acquisition and extinction (Burgos-Robles et 
al., 2009; Santini et al., 2008; Burgos-Robles et al., 2008). However, the specific 
involvement of the vmPFC excitatory synapses in fear learning or extinction was unclear. 
Findings from the Pattwell et al. (2012a) mouse studies showing potentiation of the PL 
excitatory synapses after fear acquisition in P23 and adult mice, and their subsequent 
depotentiation upon extinction, suggest that the PL excitatory synapses dynamically 
regulate fear expression. More importantly, the simultaneous potentiation of the IL 
excitatory synapses in adult fear-extinguished mice provides an additional mechanism by 
which vmPFC excitatory synapses mediate extinction. The PL projects to the basolateral 
amygdala and might exert excitatory effects on the central amygdala to enhance fear 
(Vertes, 2004; Vertes, 2006), but on depotentiation, the PL L5 pyramidal neurons might 
reverse this fear-enhancing effect. In addition, the enhanced glutamatergic IL output 
during fear extinction might facilitate the intercalated cell-mediated feed-forward 
inhibition of the central amygdala, resulting in decreased fear response (Pare et al., 2004; 
Milad & Quirk, 2002; Quirk et al., 2006; Likhtik et al., 2005; Phelps et al., 2004). 
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However, these synaptic plasticity changes in the PL and IL observed in P23 and adult 
mice are absent in adolescent mice, suggesting that the vmPFC is not similarly engaged 
in the regulation of learned fear at this age. Given the delayed development of cortical 
GABAergic transmission, it is plausible that an imbalance in inhibitory synaptic 
transmission during adolescence interferes with synaptic plasticity in the mPFC 
(Chattopadhyaya et al., 2004; Kilb 2011). These experiments identify unique synaptic 
properties in the vmPFC that may underlie developmentally regulated differences in fear 
extinction that extend to the human species. 
 
During adolescence, there is altered vmPFC synaptic activity and decreased fear-
extinction behavior compared with younger and older ages, which may provide insights 
into the efficacy of treatments for anxiety disorders that rely on extinction mechanisms 
during this developmental period. In particular, the human data presented here, along 
with the supporting mouse data, suggest that treatment response to exposure-based 
cognitive behavioral therapy would vary nonlinearly across age, with the poorest 
response in adolescents, highlighting the importance of optimizing treatment strategies 
based on age. 
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Chapter 3 
 
Parallel effects of genetic variation in endocannabinoid signaling on 
frontolimbic circuitry and function in adult humans 
 
 
Introduction 
 
The endocannabinoid system has been implicated in human anxiety (Hariri et al., 
2009; Gunduz-Cinar et al., 2013a; Hill et al., 2008). The ligand, anandamide (AEA), an 
endogenous cannabinoid (eCB) that binds to the CB1 receptor, is proposed to play a 
central role in this effect (Gunduz-Cinar et al., 2013a; Gunduz-Cinar et al., 2013b). 
FAAH is a catabolic enzyme and primary regulator of AEA signaling in the brain 
(Cravatt et al., 2005). In humans, differential expression of FAAH protein is associated 
with a common SNP (C385A; rs324420) for which ~38% of individuals of European 
descent are carriers (AC, AA genotypes) (Abecasis et al., 2012). This polymorphism 
leads to the substitution of an evolutionarily conserved proline at amino acid position 129 
with a threonine residue, which in turn renders the FAAH protein more vulnerable to 
proteolytic degradation. Accordingly, the FAAH C385A SNP enhances eCB signaling by 
reducing steady state levels of FAAH protein, which leads to elevated AEA levels (Sipe 
et al., 2002; Sipe et al., 2010; Chiang et al., 2004). In humans, FAAH C385A has been 
associated with variation in reactivity to threat (Hariri et al., 2009).  While animal studies 
featuring pharmacologic manipulations and genetic knockout of FAAH have shown 
FAAH C385A is implicated in anxiolytic behaviors including enhanced fear extinction 
learning (Gunduz-Cinar et al., 2013a; Kathuria et al., 2003; Chhatwal et al., 2005), the 
effect of the FAAH C385A SNP to facilitate enhanced fear extinction learning has not 
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previously been tested in humans. In this study,  a Pavlovian fear conditioning paradigm 
was used to test the effect of the FAAH C385A SNP on fear extinction learning in human 
adults. Additionally, the anxiolytic phenotype of the FAAH variant A allele was 
characterized using standard measures of anxiety (STAI; State-Trait Anxiety Inventory).  
 
Methods 
 
Participants 
 
40 adult volunteers completed the study (Non A carriers: n = 22; 13f, Mean age = 
25.2, sd= 2.8; 9m, mean age = 24.4, sd = 4.7; A carriers: n = 18, 8f, mean age = 20.25, sd 
= 4.7, 10m, mean age = 23, sd = 4.7). All participants were screened for exclusionary 
criteria, including hearing impairment, color blindness, diagnosed animal phobias and 
neurological and psychiatric disorders, as well as provided written consent prior to the 
experiment. Trait anxiety was assessed using the Spielberg State-Trait Anxiety Inventory 
trait subscale (STAI-T). 
 
Experimental Procedure 
We utilized a two-day fear conditioning/extinction paradigm. Acquisition 
occurred on experimental day 1 and extinction occurred 24 hours later on experimental 
day 2. Acquisition and extinction took place in different visual contexts consisting of 
pictures of rooms presented on the computer screen (Context A & B) (Milad et al., 2005). 
Cues were two colored windows (blue and yellow) that were otherwise black, embedded 
within each visual context. The unconditioned stimulus (US) was a hybrid consisting of 
auditory and visual components. The visual component was derived from a set of 
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validated aversive pictures from the International Affective Picture Series (Lang et al., 
2005). The auditory component was a validated custom-designed hybrid of white noise 
and a 1000Hz tone with duration of one second, intensity tiered for smooth onset and 
offset (Pattwell et al., 2012; Soliman et al., 2010; Levita et al., 2009). Fear acquisition 
took place in Context A. One cue was paired with the US at a 50% reinforcement rate 
(CS+). Each presentation of the US consisted of the same sound and a different picture. 
The other cue (CS-) was never followed by the US. Participants were presented 32 trials 
during acquisition (8 CS+US, 8 CS+ and 16 CS-). Twenty-four hours later, participants 
returned for experimental day 2, which took place in Context B and consisted of a 32-trial 
extinction session (16 CS+, 16 CS-). Stimuli were presented in a pseudo-randomized 
order, defined by non-consecutive CS+USs during conditioning and no more than three 
consecutive squares of the same color in any session. Visual contexts, stimuli and script 
orders were counterbalanced across subjects. Fear response was measured by skin 
conductance response (SCR), an index of autonomic nervous system activity (LaBar et al, 
1998). Differential fear responding was calculated by subtracting normalized and scaled 
SCR to the CS- from corresponding CS+ responses. Only subjects who showed fear 
acquisition (magnitude of SCR to the CS+ was greater than to the CS- during acquisition) 
were included in the analyses. In this experiment, half the participants were randomly 
assigned to either a reconsolidation update or extinction only condition. Participants who 
were assigned to the reconsolidation update condition received a single presentation of 
the CS+, unpaired with the aversive stimulus, prior to a 10-minute rest period followed 
immediately by the extinction session.  
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Physiological Response Measurement and Analysis  
 
Skin conductance response (SCR) was acquired using disposable snap electrodes 
pre-gelled with isotonic gel, which were attached to the distal phalanx of the second and 
third digits of the left hand. The signal was recorded and amplified using a skin 
conductance recording system  (MP35; Biopac) in combination with AcqKnowledge 
software (Biopac). E-prime software (Psychology Software Tools) was used to control 
the presentation of visual and auditory stimuli and send time markers to the skin 
conductance recording system for each context and stimulus onset/offset. The SCR was 
sampled at 200 Hz with a 1-HZ filter applied. SCR was analyzed manually. For each 
individual subject, data were smoothed. Measurable peaks were identified as the first 
SCR response that occurred within .5-4.5 s following stimulus onset as defined by the 
difference between trough and peak being equal to or greater than .02 uS 
(microsiemens)(Schiller et al., 2013). A zero value was added into the analysis when no 
peak was detected. SCR scores were square root-transformed to normalize the 
distribution   and   were   then   scaled   to   the   participant’s   largest   response   to   the   CS+US  
during acquisition to normalize responses across participants.  These SCR scores were 
averaged for each participant for each stimulus type separately. All SCR responses 
reported reflect differences between responses to the CS+ and corresponding CS-.  
SCR was recorded at a sampling frequency of 200Hz with a 1Hz filter and 
manually smoothed. After each stimulus presentation, the first SCR peak occurring 
within 0.5-4.5s   was   considered   the   subject’s   response   to   that   stimulus.   Responses,   as  
estimated by the difference between trough and peak, were only included in analysis 
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when greater than 0.02µS (Schiller et al., 2010a). Responses smaller than this threshold 
were replaced with zeros during analysis. During analysis, individual SCR responses 
were  square  root  transformed  and  scaled  to  that  participant’s  largest  CS+US  acquisition  
response. Normalized SCR scores were averaged separately by stimulus type (CS+, CS-, 
CS+US). All presented responses were calculated as the difference between CS+ and CS- 
responses. We binned extinction trials into early (mean differential CS+ responses of 
trials 1 through 5) and late blocks (mean differential CS+ responses during trials 6 
through 11). Only subjects who showed fear acquisition (magnitude of SCR to the CS+ 
was greater than to the CS- during acquisition) were included in the analyses.  
 
Results 
 
We tested humans (22 CC-alleles, 18 A-allele carriers; Table 3.1), using cued fear 
conditioning with extinction on the following day. There was no main effect of FAAH 
genotype on fear acquisition [t(38) = -1.013] (Figure 3.1), suggesting that any subsequent 
group differences in fear extinction are not related to strength of conditioning.  
 
 
 
Figure 3.1. Fear acquisition 
in humans with FAAH 
C385A polymorphism.  
Fear acquisition in A allele 
carriers  (n = 18) relative to 
C homozygotes (n = 22) as 
measured by calculating 
differential skin conductance 
responses (SCR) between a 
cue previously paired with 
an aversive stimulus (CS+) 
and a cue never paired with 
an aversive stimulus (CS-) 
on the last 3 trials of 
acquisition [t(38) = -1.013] 
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Human A allele carriers showed facilitated fear extinction learning, as indexed by 
decreased galvanic skin responses during late trials of extinction training [(F(1,36)=4.35, 
P < 0.044)], controlling for potential age and gender effects between genotypic groups 
(Fig. 3.2a). This is in accordance with parallel findings in mice (Divencha et al., 2014) 
that showed a significant effect of genotype on freezing behavior during extinction 
(ANOVA with post-hoc Bonferroni test [F(2,116)=6.8, P < 0.01]) (Fig. 3.2b), with 
heterozygous [P < 0.05] and homozygous [P < 0.01] FAAH C385A mice showing less 
freezing behavior compared to wild types in late trials, but no difference in early trials 
(Fig. 3.2b) or in fear acquisition. These parallel effects of enhanced fear extinction in 
FAAH A-allele carriers have not previously been established for both mice and humans. 
 
Figure 3.2. Enhanced Cued Fear Extinction in humans and mice with FAAH 
C385A. (a) Extinction, indexed by differential skin conductance response (SCR) [(CS+) 
– (CS-)], in 18 A allele carriers and 22 C homozygotes. Trials were binned into early 
(average of the first 5 trials) and late (average of the following 6 trials). (b) Fear 
extinction, time spent freezing to cue, was tested in wild type (FAAHC/C; n = 21), 
heterozygous (FAAHC/A; n = 20) and homozygous knock-in mice (FAAHA/A; n = 20). 
Extinction trials were binned into early (average of extinction day 1) and late trials 
(average of extinction day 4). Means ± SEM presented. *P < 0.05, #P < 0.05 
heterozygous knock-in mice vs wild-type controls, **P < 0.01 homozygous knock-in 
mice vs wild-type controls. 
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We further characterized the anxiolytic phenotype of the FAAH variant A allele 
in our human participants using standard measures of anxiety-related behaviors (STAI; 
State- Trait Anxiety Inventory). In accordance with our results showing enhanced fear 
extinction in human and mouse FAAH A-allele carriers, reduced levels of trait anxiety 
were reported by A allele carriers [t(38) = -2.24, p = .03](Figure 3.3A), an effect also 
seen in a separate cohort of 137 humans [t(135)=2.30, P = 0.019] (Figure 3.3B) 
(Divencha et al, 2014). 
  
b 
 
a 
Figure 3.3. Inverse relationship between FAAH C385A and trait anxiety in two distinct 
human adult populations. (a) Relationship between number of mutant FAAH C385A alleles 
and STAI trait anxiety was examined in the human adults in the present study, revealing a 
significant negative correlation [t(38)=-2.247, P = 0.03]. (b) A separate population of 137 
adults showed a similar negative correlation [t(135)=2.30, P = 0.019] (Divencha et al., 2015). 
Means ±SEM presented.  
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Discussion 
 
The data presented here provides evidence that the FAAH 385A SNP leads to 
enhanced fear extinction learning and decreased trait anxiety in human adults. While 
these results are derived from a small population relative to that typically seen in genetics 
studies, these findings are supported by concordant data from a set of parallel human and 
animal studies. The animal studies assessed fear extinction learning and trait anxiety 
utilizing a knock-in mouse that expresses the variant A (threonine) allele of the FAAH 
polymorphism in place of the conserved ancestral C (proline) allele, recapitulating the 
genotypic variation naturally observed only in humans. These studies replicated the 
behavioral findings from the human extinction sample and provided the opportunity to characterize the effects of the FAAH variant in the brain. The human studies examined 
the effect of the FAAH 385A SNP on the neural circuitry underlying fear acquisition and 
extinction learning through analysis of resting state fMRI (rs-fMRI) data, as well as 
replicating the trait anxiety findings in a separate population of 137 adult subjects. These 
studies enabled the demonstration of parallel molecular, circuit-level and behavioral 
phenotypes in humans and in the knock-in mice carrying this variant (Divencha et al., 
2015) and is presented below.  
 
Enhanced connectivity between ventromedial prefrontal cortex (vmPFC) and 
amygdala in humans and mice with the FAAH C385A polymorphism  
 
In humans, FAAH C385A has been associated with variation in reactivity to 
threat (Hariri et al., 2009). However, it is unclear how the FAAH C385A polymorphism 
might alter the circuitry implicated in this behavioral domain. Fear conditioning studies 
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in animal models suggest that dynamic interaction between the amygdala and two 
subregions of the prefrontal cortex (PFC) can drive opposing behavioral responses to 
threat (Vidal-Gonzalen et al., 2006; Laurent & Westbrook, 2009; Sierra-Mercado et al., 
2011; Phelps & LeDoux, 2005). Whereas the prelimbic region (PL) promotes fear 
expression, the infralimbic region (IL) promotes the regulation of threat responses. 
Neuroimaging studies examining correlates of these opposing behaviors in humans 
suggest that a dorsal anterior cingulate cortex (dACC) region exhibits functional parallels 
to rodent PL and a subgenual region of ventromedial PFC (vmPFC) exhibits functional 
parallels to rodent IL (Hartley & Phelps, 2010; Phelps et al., 2004; Milad et al., 2007; 
Schiller & Delgado, 2010b).  
 
Species-specific connectivity analyses were performed focusing on key regions 
within the frontoamygdala circuitry that regulate fear responses and fear extinction 
learning. First, resting state connectivity between the subgenual vmPFC and the 
amygdala and the dorsal ACC and the amygdala was examined in humans by genotype. 
A allele carriers showed increased correlation between the blood oxygen level-dependent 
(BOLD) signals in the vmPFC and the bilateral amygdala (Divencha et al., 2014). This 
pattern was selective to subgenual vmPFC–amygdala connectivity with no genotypic 
difference in dorsal ACC-amygdala connectivity. A substantial literature suggests that 
stronger inverse functional connectivity between the vmPFC and the amygdala during 
emotion-related tasks is associated with decreased anxiety or negative emotion (Kim et 
al., 2004; Urry et al., 2006; Hare et al., 2008). In contrast, positive resting state functional 
connectivity between these regions has been associated with lower anxiety (Kim et al., 
2011; Burghy et al., 2012; Hahn et al., 2011). The human resting state analysis is 
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consistent with this broader literature suggesting that greater positive corticoamygdala 
connectivity at rest predicts more effective emotional control (Kim et al., 2011a; Kim et 
al., 2011b).  
 
Anterograde (adeno-associated virus expressing enhanced green fluorescent 
protein; AAV2-eGFP) and retrograde (fluorogold) tracers were used in the FAAH knock-
in mouse to delineate the precise location and directionality of genotypic differences in 
frontoamygdala circuitry. These tract-tracing experiments revealed increased IL to 
basolateral amygdala (BLA) projections in mice, but no genotypic differences in 
ascending projections from the BLA to the IL. Mirroring the human imaging findings, no 
genotypic differences in descending or ascending projections were found between the PL 
and BLA in the mouse (Divencha et al., 2014). Selective increases in descending IL-
amygdala projections offer a structural neuroanatomical basis for the increased functional 
connectivity in frontoamygdala circuitry in human A allele carriers and may help explain 
reported genotypic differences in emotion regulation (Hariri et al., 2009).  
 
Enhanced cued fear extinction in mice with the FAAH C385A polymorphism  
 
Mice showed a significant effect of genotype on freezing behavior during 
extinction with heterozygous and homozygous FAAH C385A mice showing less freezing 
behavior compared to wild types in late trials, but no difference in early trials or in fear 
acquisition (Figure 3.2b) (Divencha et al., 2014). These results are consistent with 
reported effects of pharmacological and genetic knockout manipulations of FAAH 
expression in mice (Gunduz-Cindar et al., 2013; Moreira et al., 2008; Chhatwal & 
Ressler, 2007) and with the effects reported here in human adults. These parallel effects 
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of enhanced fear extinction in FAAH A-allele carriers have not previously been 
established for both mice and humans.  
Decreased anxiety levels in mice and humans with the FAAH C385A 
polymorphism 
 
In accordance with the data reported here, the anxiolytic phenotype of the FAAH 
variant A allele was characterized in both mice and an additional cohort of humans using 
standard measures of anxiety-related behaviors. In mice, two standard measures of 
anxiety-like behaviors were performed that place subjects in conflict situations. In an 
elevated plus maze (EPM) test, homozygous mutant mice spent a higher percentage of 
time in the open arms than wild-type controls, indicative of reduced anxiety-like 
behavior. Mice in the novelty-induced hypophagia (NIH) task were trained to approach a 
reward (sweetened milk) in their home cage and then tested in a novel, brightly lit cage. 
Within this task, the latency to approach and drink the sweetened milk is a measure of 
anxiety-related behavior (Dulawa & Hen, 2005). FAAH C385A mice showed decreased 
latency to drink milk in the NIH task, suggesting decreased anxiety phenotype. Neural 
correlates of the observed anxiolytic effects were explored by examining neural activity, 
as indicated by expression of the early immediate gene c-fos (Dragunow and Faull, 1989), 
in the BLA following the NIH task. Data showed a main effect of genotype on BLA c-
Fos expression in mutant knock-in mice in a dose-dependent pattern, suggesting 
decreased engagement of the BLA in these mice during a stressful exposure (Divencha et 
al., 2014). This reduced activation of the amygdala in response to stressful stimuli is 
consistent with reductions in amygdala activity in response to threat in human FAAH A 
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allele carriers (Hariri et al., 2009). In an additional cohort of 137 humans, A allele 
carriers reported reduced levels of trait anxiety (STAI; State-Trait Anxiety Inventory), 
replicating the pattern shown in the human fear extinction sample (Figure 3.3b) 
(Divencha et al., 2014). Collectively, this evidence from mice and humans suggests the 
FAAH 385A polymorphism is associated with lower trait anxiety.  
 
 Using a vertically integrated approach in parallel studies in humans and mice, 
these studies collectively provide converging evidence supporting the relevance and 
impact of the FAAH C385A polymorphism on brain biochemistry, neurocircuitry, 
behavior and symptoms. The mouse model was validated by showing that the FAAH 
variant allele leads to reductions in FAAH protein and enzymatic activity and increases in 
AEA levels in the brain. Subsequent analyses in humans and mice elucidated circuit level 
and behavioral phenotypes not previously established in human carriers with this SNP. 
Enhanced fear extinction has been shown in both humans and mice with the C385A 
mutation. In addition, the finding of selectively enhanced frontoamygdala connectivity in 
both mouse and human carriers provides a mechanistic explanation for these behavioral 
effects of the A allele through enhanced regulation of basolateral amygdala responses to 
threat by the infralimbic (mouse) and ventral medial prefrontal (human) cortex. Thus, this 
variant SNP may represent a gain-of-function in the domain of anxiety-related behaviors 
and may prove valuable in determining for whom and for what symptoms FAAH 
inhibitors or exposure-based therapies that build on basic principles of extinction learning 
will be most efficacious. In this way, therapeutics might be tailored to an individual to 
move from standard care to more precise personalized care. A persistent problem 
identified in animal models of disease is a failure of the findings to translate to the human 
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in clinical trials. These studies translate mouse behavioral and brain findings to show 
their human relevance using parallel paradigms and imaging tools across species. Thus, 
this work and integrated approach fill a large translational gap from mouse to human.   
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Chapter 4 
Extinction during memory reconsolidation blocks recovery of fear in 
adolescents 
 
 
Introduction 
 
Fear is an adaptive function that allows an individual to respond appropriately to 
the imminent arrival of danger. For most individuals who experience such events, fear 
responses naturally extinguish across time as the danger diminishes.  However, when the 
fear persists long after the danger has passed, this can lead to the development of stress 
and anxiety-related disorders. These disorders are the most common of all the psychiatric 
illnesses and frequently emerge during adolescence, often persisting into adulthood 
(Merikangas et al., 2010), with a majority of all adults first meeting diagnostic criteria 
during childhood or adolescence (Kim-Cohen et al., 2003). 
 
The most effective evidence-based behavioral treatment for anxiety and stress-
related disorders is exposure-based cognitive behavioral therapy (CBT) (Rothbaum et al., 
2010).  Exposure-based CBT is based on the principles of fear extinction and involves 
identifying the triggers for the underlying anxiety and desensitizing the patient to these 
triggers with repeated exposures. As presented in Chapter 2, emerging evidence from 
both rodents and humans suggests that adolescents are less capable of extinguishing fear 
memories relative to younger or older animals (Pattwell et al., 2012a; McCallum et al., 
2010). While the amygdala, medial prefrontal cortex and hippocampus are known to 
constitute a core neural circuit in fear extinction learning (LeDoux 2000), this circuit is 
functionally immature during adolescence (Pattwell et al., 2012a; Hare et al., 2008; Kim 
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et al., 2009; Kim et al., 2011; Milad & Quirk 2012). Diminished fear extinction is thought 
to be a risk factor for anxiety and stress related disorders. Thus emerges the paradoxical 
situation in which the most common behavioral treatment approach for anxiety and 
stress-related disorders in adolescents is built on the same learning process that mediates 
these   individual’s   vulnerability   to   clinical   anxiety   in   the   first   place.   This   suggests   that  
extinction-based therapies may be less effective for adolescents (Drysdale et al., 2013) 
and that alternative or optimized treatments that bypass the need for fear regulation 
circuitry may be more effective.   
 
Recent studies have shown that an alternative method for attenuation of fear 
memories is that of memory reconsolidation (Schiller et al., 2010a; Schiller et al., 2013; 
Agren et al., 2012, Monfils et al., 2009). Memory reconsolidation is based on the notion 
that memories are dynamic rather than stable (Sara et al., 2010; Misanin et al., 1968). 
Every time a consolidated memory is retrieved, it returns to a fragile state and must 
restabilize again before becoming a stable memory (Nader et al., 2000; Dudai 2006). The 
temporal window of increased plasticity during which a memory undergoes 
reconsolidation begins approximately 10 minutes after memory retrieval and continues 
for at least one hour (Monfils et al., 2009), presenting an opportunity during which the 
memory can be updated and altered.  Rodent (Nader et al., 2000; Monfils et al., 2009) and 
human imaging studies (Schiller et al., 2013; Agren et al., 2012) suggest that 
reconsolidation of fear memory is primarily mediated by the amygdala, rather than 
prefrontal circuitry.  These findings suggest a plausible way in which adolescents may be 
able to overcome fear memories via interventions that alter memories within the 
amygdala. 
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In the current study we used a behavioral method employed in human adults 
(Schiller et al., 2010a; Agren et al., 2012; Schiller et al., 2013) and in rodents (Monfils et 
al., 2009; Baker et al., 2013) to test whether fear memories could be attenuated in human 
adolescents. We hypothesized that adolescents who received a reminder cue 10 minutes 
prior to extinction training would  (1) show less fear recovery relative to adolescents who 
only received extinction training (no reminder cue); and (2) look similar to adults who 
received the reminder cue. This hypothesis was based on evidence of adolescents having 
diminished prefrontally-mediated extinction learning (Pattwell et al., 2012; McCallum et 
al., 2010) and of reconsolidation update altering the memory at the level of the amygdala, 
rather than the prefrontal cortex (Schiller et al., 2013; Agren et al., 2012; Monfils et al., 
2009; Nader et al., 2000). 
 
Methods  
 
Participants 
 
Seventy-four of 128 participants completed the study including 38 adolescents 
aged 12 to 17 (extinction condition: n=19 (11f), mean age = 14.6, sd = 1.8, mean Tanner 
staging = 3.98, sd = .87, range 2-5; reconsolidation condition: n=19 (9f), mean age = 
14.7. sd=1.6, mean Tanner staging = 3.89, sd = .56, range = 2-5) and 36 adults aged 18 to 
32 (extinction condition: n = 18 (9f), mean age = 24.7, sd = 3.6; reconsolidation 
condition: n = 18 (9f), mean age = 24.4, sd = 4.3.) The two adolescent experimental 
groups did not differ in pubertal development as indexed by Tanner pubertal staging 
(Fisher Exact Test, p = .09).  Seven of the adolescents had a Tanner stage of 5 (Extinction 
group: 6; reconsolidation update group: 1).  The distribution of the sexes by age group 
53  
and experimental condition were: Adult, extinction:  n=18 (9f); Adult, reconsolidation: n 
= 18 (8f); Adolescent, extinction: n=19 (11f); Adolescent, reconsolidation: n = 19 (9f). 
Fifty-four (54) participants (33 adults, 21 adolescents) were excluded from analysis 
because they failed to show a reliable SCR and/or fear acquisition (magnitude of SCR to 
the CS+ was not greater than responses to the CS- during acquisition or during the first 
block of extinction (n = 47, 30 adults, 17 adolescents) or they failed to complete the 3-
day study due to attrition (n = 7, 3 adults, 4 adolescents)). All participants were screened 
for exclusionary criteria, including hearing impairment, color blindness, diagnosed 
animal phobias and neurological and psychiatric disorders, as well as provided written 
consent prior to the experiment. Trait anxiety was measured by using the Spielberg State-
Trait Anxiety Inventory Trait subscale (STAI-T; Spielberger, C.D., 1983) in light of 
evidence suggesting a negative correlation between trait anxiety and fear extinction 
learning (Indovina et al., 2011; Lissek et al., 2005). Trait anxiety ratings were not 
available for 3 adolescent participants.  There was no effect of age group [F (1, 67) = .13, 
p =.71], experimental condition [F (1, 67) = .03, p = .86] or interaction between age 
group and experimental condition [F (1, 67) = 2.73, p = .10] on trait anxiety. Pubertal 
development for adolescent participants was measured by self-report or parental report 
using two standardized scales (Petersen et al., 1988; Tanner, 1962). Tanner staging 
correspondence ranged from 2 to 5 (mean = 3.9, sd = .72). The two adolescent 
experimental groups did not differ in pubertal development (Experimental group: mean = 
3.98, sd = .87, range = 2 - 5; Reconsolidation update group: mean = 3.89, sd = .56, range 
= 2-5) All three sessions (days) of the experiment occurred within two hours of the 
original testing session for each participant. Participants were tested between 10 AM to 6 
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PM. There were no significant differences in time of day at which experiments were 
performed by experimental condition [F (1, 73) = 1.055, p=.426], age group  [F  (1, 73)= 
1.456, p = .128], nor for age by experimental group [F (1, 70) = .307, p=.581].   
 
Experimental Procedure 
 
We utilized a differential fear-conditioning paradigm with partial reinforcement 
that took place over three days in two different visual contexts (Figure 1). Visual contexts 
consisted of two different scenes, a bedroom and a kitchen, created using 3D design 
software (Google Sketch-Up 2008, Mountain View, CA). Conditioned stimuli consisted 
of two colored windows (blue and yellow) embedded within each visual context. The 
unconditioned stimulus was a hybrid consisting of validated, negatively valenced animal 
pictures (Lang et al., 1999) and a validated aversive sound (Levita et al., 2009).  The IAPS 
pictures used as UCSs were of threatening animals (IMG #s 1052 (fanged snake), 1120 
(fanged snake), 1200 (spider), 1201 (spider on shoulder), 1205 (spider), 1300 (snarling 
dog), 1302 (snarling dog), 1932 (shark). Visual contexts (Context A and B), stimuli and 
script orders were counterbalanced across subjects. Prior to starting the experiment, 
participants were randomly assigned to either the reminder (reconsolidation update) or no 
reminder  (extinction)  conditions  and  told  they  should  “pay  close  attention  to  everything  
they  see  and  hear  and  understand  the  relationship  between  all  of  these  things.” 
 
For each experimental session, stimuli were presented in a pseudo-randomized 
order, defined by no consecutive CS+USs during conditioning and no more than three 
consecutive squares of the same color in any session. Acquisition, extinction and re-
extinction were each run as one continuous session, lasting 12m, 24s (conditioning, 
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experimental day 1) and 12m, 16s (extinction and re-extinction, experimental days 2 and 
3). For the acquisition phase of the experiment, the context was presented for 3s (with a 
black background in the window frame where the cue will be presented), followed by 
stimulus presentation for 7s and presentation of the US for 1s. The timing of the trials for 
the extinction and re-extinction phases was identical to that of the acquisition phase with 
the exception of no presentation of the CS+US. The intertrial interval (ITI) for all phases 
was 13s, providing sufficient time for SCR to return to baseline. On experimental day 1, 
one colored shape (the CS+) was paired on 50% of the trials with a compound aversive 
stimulus (unconditioned stimulus, CS+US) within Context A. The US consisted of an 
aversive sound presented simultaneously with an aversive picture. Each presentation of 
the US consisted of the same sound and a different picture. The other colored shape (CS-) 
was never followed by the aversive stimulus. Partially pairing the CS+ with the tone 
allowed us to isolate and analyze responses to the CS+ independent of responses to the 
US. Participants were presented with 32 trials on Day 1 (8 CS+US, 8 CS+, 16 CS-).  
Twenty-four hours later, participants returned for experimental day 2.  Prior to starting, 
participants  were   instructed   they   “may   see   scary pictures and/or hear annoying sounds 
again”   and   reminded   to   again   “pay   close   attention   to   everything   they   see   and   hear.”  
Participants in the extinction condition started with a 10-minute rest period, in front of 
the test computer. This was followed by a 32-trial extinction session (16 CS+, 16 CS-) in 
Context B. Participants who were assigned to the reconsolidation update condition 
received a single presentation of the conditioned stimulus (in context B), unpaired with 
the aversive stimulus, prior to the 10-minute rest period. These participants received one 
less CS+ trial during the extinction session (15 CS+, 16 CS-) in order to match the total 
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number of CS+ trials across experimental conditions. All participants viewed a cartoon 
video of Tom and Jerry (Warner Brothers) during the 10-minute break, presented on the 
same computer screen on which they viewed the experiment. Twenty-four hours later, 
participants returned for experimental day 3. Participants were instructed similarly as 
they were prior to experimental day 2. Participants then received a single presentation of 
the US, unpaired with the conditioned stimulus (reinstatement). This was followed by a 
32-trial re-extinction session (16 CS+, 16 CS-). The first 2 trials were either CS+, CS- 
(script order 1) or CS-, CS+ (script order 2).   
 
Physiological Measurement and Analysis 
 
Skin conductance response (SCR) was acquired using disposable snap electrodes 
pre-gelled with isotonic gel, which were attached to the distal phalanx of the second and 
third digits of the left hand. The signal was recorded and amplified using a skin 
conductance recording system  (MP35; Biopac) in combination with AcqKnowledge 
software (Biopac). E-prime software (Psychology Software Tools) was used to control 
the presentation of visual and auditory stimuli and send time markers to the skin 
conductance recording system for each context and stimulus onset/offset. The SCR was 
sampled at 200 Hz with a 1-HZ filter applied. SCR was analyzed manually. For each 
individual subject, data were smoothed. Measurable peaks were identified as the first 
SCR response that occurred within .5-4.5 s following stimulus onset as defined by the 
difference between trough and peak being equal to or greater than .02 uS 
(microsiemens)(Schiller et al., 2013). A zero value was added into the analysis when no 
peak was detected. SCR scores were square root-transformed to normalize the 
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distribution   and   were   then   scaled   to   the   participant’s   largest response to the CS+US 
during acquisition to normalize responses across participants.  These SCR scores were 
averaged for each participant for each stimulus type separately. All SCR responses 
reported reflect differences between responses to the CS+ and corresponding CS-. 
  Figure 4.1. Experimental stimuli, design and timeline. (a) Contexts (A & B) were 
pictures   of   one   of   two   rooms   (kitchen,   child’s   room)   appearing   on   the   computer   screen.  
Conditioned stimuli (CS- & CS+) were yellow and blue windows (counterbalanced) in the 
rooms. The unconditioned stimulus (US) was a hybrid with visual (scary animal picture) 
and auditory (aversive noise) components. (b) Participants underwent acquisition on 
experimental day 1, extinction or reconsolidation update on experimental day 2 and fear 
recovery test (re-extinction) on experimental day 3 (All images by D.C. Johnson)     
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Results 
 
 
The results from the acquisition phase are shown in Fig. 4.2A. Adolescents and 
adults showed equivalent fear acquisition across age groups  [F(1, 70) = .956, p = .33] 
and across experimental conditions [F(1, 70) = .23, p = .64]. There was only a main effect 
of stimulus type [F(1,70)=54.78, p < .0001] indicating greater SCR to the CS+ than the 
CS- (t(73) = 7.52, p < .0001) across all participants. These results confirm that 
participants learned to distinguish between the CS+ (threat cue) and the CS- (safety cue). 
Thus subsequent group effects are unlikely due to group differences in reactivity to 
specific stimulus categories or strength of conditioning.  
  
Similar to our previous findings, adolescents showed diminished extinction 
learning over time relative to adults as indicated by an age x time interaction [F(1, 70) = 
3.91, p = .05]. Post hoc t-tests revealed a significant decrease in the mean SCR difference  
[(CS+) – (CS-)] score from early to late trials during extinction learning for the adults 
[t(35) = 4.34, p < .0002] but not for the adolescents [t(37) = 1.78, p=.08] (Fig. 4.2B).  
This pattern of attenuated fear extinction learning in adolescents compared to adults is in 
concordance with our previous findings in humans and rodents (Pattwell et al., 2012). 
  
 
59  
 
Figure 4.2. Acquisition, extinction and recovery of fear memory by age group.       
(A) There were no differences in differential skin conductance response (SCR) of the 
CS+ and CS- by age group during acquisition [F(1, 70) = .979, p=.33] and a main effect 
of time [F(1, 70) = 4.564, p = .036] in the mean SCR difference (CS+ - CS-) score from 
early to late trials. (B) There was an interaction of age group x time in extinction learning 
as indexed by differential SCR of the CS+ and CS- [F(1, 70) = 3.913, p = .05]. Post hoc t-
tests showed significant within-session extinction learning for adults (t = 4.34, p < .0002) 
but not for adolescents (t = 1.78, p = .08). (C) Diminished fear memory with 
reconsolidation update.  Participants who were reminded of the conditioned stimulus 10 
minutes prior to extinction showed no recovery of fear 24 hours later, as indexed by SCR 
responses to the first CS+ trial of re-extinction (experimental day 3). There was a main 
effect of experimental condition [F(1, 70) = 6.263, p = .015] and no age group x 
experimental condition interaction [F(1, 70) = .002, p = .966].  All results are presented 
as a mean ± SEM. *p = .05, **p < .05. 
 
 
Following reinstatement (isolated presentation of the US), adolescents and adults 
who received the reminder cue 10 minutes prior to extinction learning on the previous 
day, showed a diminished fear response. Conversely, adolescents and adults who did not 
receive a reminder cue showed robust recovery of the fear memory as indicated by the 
main effect of experimental condition (Figure 4.2C) [F(1, 70) = 11.72, p < .001]. These 
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data suggest that reinstatement of fear after extinction training can be attenuated if 
extinction occurs within the temporal window of reconsolidation.  
 
Discussion 
 
The results suggest that reconsolidation update attenuates fear recovery in 
adolescents similar to adult humans (Schiller et al., 2010a, Agren et al., 2012; Schiller et 
al., 2013; Steinfurth et al., 2014; Liu et al., 2014). While extinction learning involves the 
encoding of a new competing memory that leaves the original fear memory intact (Milad 
& Quirk  2012), the current results suggest that the safety information provided during 
post-retrieval extinction is integrated into the original fear memory altering its affective 
value even in adolescents who show diminished extinction learning. 
 
These findings are promising in that they suggest fear extinction learning, a form 
of fear regulation dependent on strong functional connectivity between the vmPFC and 
the amygdala (Milad & Quirk   2012), is not the only means by which adolescent humans 
can regulate fear. Unlike other forms of memory with more diffuse neural representations 
(Squire & Knowlton 2000), cued fear memories are thought to be stored in the amygdala 
(Schafe et al., 2005). In concordance with these data, recent human fMRI studies have 
shown little if any involvement of the vmPFC in extinction following reconsolidation 
update (Schiller et al., 2013; Agren et al., 2012), suggesting that reconsolidation of fear 
memories occurs independent of vmPFC activation in humans. These findings could 
explain why reconsolidation successfully blocked fear recovery in the adolescents in the 
present study. While this hypothesis is consistent with the human adult imaging findings 
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(Schiller et al., 2013; Agren al., 2012), further studies would be required to test the neural 
correlates of the behavioral effects we report here for adolescents. 
 
Contextual vs. Cued Fear 
 
A cued fear memory can return after extinction if the conditioned stimulus is 
encountered in the original conditioning context or in a novel context (Bouton et al., 
2004). As noted, we employed a virtual context manipulation in this study whereby 
acquisition occurred in context A, and extinction (with or without pre-extinction 
retrieval) and re-extinction occurred in context B (A-B-B) (Milad et al., 2005). This 
manipulation was used so measures of the CS-US association could be assessed during 
extinction and re-extinction, independent of the expression of contextual fear. However, 
all three days of this study were carried out by the same experimenter, in the same room, 
laboratory, building and institution. These elements constitute salient dimensions of the 
experimental context, which is formed by binding all of the contextual elements present 
during the study into an integrated and coherent representation (Maren et al., 2013). It 
could be argued that the reminder trial, extinction and re-extinction phases of this study 
occurred in a hybrid context that contained substantial elements of the acquisition 
context, suggesting some level of contextual ambiguity may need to be resolved in order 
to correctly assess the affective value of the conditioned stimulus.  Evidence suggests that 
the process of disambiguating the affective value of discrete cues through learning and 
remembering contextual information is a hippocampal-dependent process (Phillips & 
LeDoux, 1992; Selden et al., 1991; Kim & Fanselow, 1992; Frankland et al., 1998; Blair 
and Fanselow, 2014). Although a full discussion of the role of the hippocampus in 
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updating fear memories during reconsolidation is beyond the scope of this manuscript, it 
is possible that the context manipulation employed in this study may have led to the 
recruitment of neural regions, such as the hippocampus, that are distinct from the neural 
correlates of reconsolidation update reported in recent human imaging studies that have 
maintained the same context across all experimental phases. (Schiller et al., 2013; Agren 
et al., 2012). Furthermore, it’s possible that context played some role in mediating the 
effect of reconsolidation to block the recovery of fear in this study. One recent study in 
adolescent mice showed that attenuation of fear after reconsolidation update only 
occurred when a retrieval cue was presented in the acquisition context and not in a novel 
context (S. Pattwell, F. Lee, unpublished data, 2015), while this effect was not present for 
adult rodents.  These findings are congruent with the results of the present study, as the 
retrieval cue was presented in a context that was substantially similar to the acquisition 
context. The aforementioned findings from Pattwell and Lee represent the possibility of a 
developmentally-mediated boundary condition on the reconsolidation update effect: the 
context in which a retrieval cue is presented could affect whether or not reconsolidation 
interference of cued fear memory is possible during adolescence.  Future studies that 
employ more potent context manipulations will be needed to test whether the context in 
which the retrieval cue is presented can render reconsolidation update less effective, or 
prevent the effect from being induced at all, in adolescent humans.      
 
Within vs Between Session Extinction 
 
It should be noted that evidence of the persistence of reconsolidation update to 
attenuate fear, as indexed by the long-term fear recovery test (e.g. one year later (Schiller 
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et al., 2010a)) is not available for the current study. Instead, we utilized reinstatement in 
this study, thought to be a potent assay by which to evoke the return of conditioned fear 
(Schiller et al., 2010a). Conditioned fear did not return in the reconsolidation update 
group after reinstatement, even in our adolescents who showed diminished within-session 
extinction, highlighting the robustness of the effect. However, adolescents who showed 
diminished within-session fear extinction learning compared to adults and received no 
reminder cue, showed similar between-session extinction (fear recovery) following 
reinstatement as adults (Fig 4.2C). It is important to distinguish between within-session 
extinction, which refers to decreases in fear response during the extinction session, and 
between-session extinction, which refers to the retention of that extinction learning when 
presented with the same CS at a later occasion (usually 24 hours). Between-session 
extinction may map more directly onto clinical models of relapse after exposure therapy 
than within-session extinction (Milad et al., 2009). Reinstatement was utilized in this 
study because it is the most potent assay by which to evoke the post-extinction return of 
conditioned fear and therefore a strong test of the reconsolidation effect (Schiller et al., 
2010a).  However, it may not be the ideal assay to test for developmental or clinical 
differences in between-session extinction retention. Future studies that test adolescent-
specific differences in between-session extinction using a milder assay such as 
spontaneous recovery (passage of time) rather than reinstatement (single or multiple 
presentation of the unconditioned stimulus prior to the fear recovery test) to evoke the 
return of fear might provide a more sensitive test of developmentally-mediated 
differences in extinction retention and would help to constrain our findings. 
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While exposure-based therapies are effective in the treatment of anxiety and stress 
disorders (McNally et al., 2005), it has been noted that as many as 40-50% of young 
people fail to fully benefit from such therapies (Walkup et al., 2008). The efficacy of 
these treatments may be impacted by age. Our data highlight how modifying the timing 
of therapeutic sessions based on principles of memory reconsolidation could lead to more 
effective attenuation of conditioned fear in adolescents (and adults). A modified version 
of an exposure-based CBT protocol based on memory reconsolidation might involve 
reminding  patients  of  why   they  are   there  when   they   first   arrive  at   the  clinician’s  office  
(i.e., reminder cue), then establishing a safe and positive rapport for approximately 10 
minutes (i.e., waiting for reconsolidation window) before initiating desensitization with 
exposure therapy. The findings may also explain why exposure-based CBT is effective 
for some adolescent patients  and  not  others,  and  for  some  clinicians  more  than  others.  It’s  
possible that positive treatment outcomes, in some cases, have been achieved through 
modified exposure-based CBT protocols that inadvertently capitalized on the principles 
of memory reconsolidation. These data provide evidenced-based support for this 
approach.  Validating such protocols would be an important next step in establishing the 
utility of modified clinical therapies for adolescents based on the principles of memory 
reconsolidation. 
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Chapter 5 
 
A personalized approach to treating fear-related disorders: 
Limitations, clinical implications, future studies and conclusions 
 
 
This thesis has identified two factors associated with diminished fear extinction 
learning in humans: the developmental stage of adolescence (Chapter 2 and 4) and 
genetic variation in FAAH (Chapter 3). These findings suggest age and genetic 
background can  increase  any  given  individual’s risk for developing fear-related disorders 
and diminish responsiveness to exposure-based cognitive behavioral therapy that build on 
the principles of fear extinction. The clinical relevance of these findings is that these 
factors (as well as additional factors such as experiential history and sex), and their 
various interactions, could be used as diagnostic criteria to identify patients with stress 
and anxiety disorder who may not respond well to extinction-based therapy (i.e. precision 
medicine). For these patients, alternative methods might be considered.  Evidence 
presented in this thesis (Chapter 4) shows that a method based on the principles of 
memory reconsolidation enhances fear regulation. Novel or modified clinical therapies 
based on these findings could lead to enhanced treatment outcomes for individuals 
diagnosed with stress and anxiety disorder.  
 
While this data suggests that developmental stage and genetic background can 
mediate fear regulatory capacity, in order for these factors to function as effective 
diagnostic markers, their role in mediating treatment effects of exposure-based CBT 
should be demonstrated.  Furthermore, while converging evidence suggests that fear 
regulation can be enhanced by updating a fear memory during the temporal window of 
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reconsolidation, several studies have failed to replicate the pre-clinical findings by 
Schiller et al. (2010a) and others. Identifying factors that prevent or minimize 
reconsolidation update of fear memory will be important in order to successfully translate 
the pre-clinical findings into clinical application. In this chapter, I present data suggesting 
that age and genotypic variation mediate exposure-based CBT outcomes. I then highlight 
two additional factors – experiential history and sex – that may play an important role in 
mediating fear regulatory capacity for any given individual across development. Next I 
present four methodological factors – the specific category of the conditioned stimuli, 
online self report of anticipated fear, acquisition memory strength and age of the fear 
memory  –  that might explain some of the discrepancies seen across reconsolidation 
update studies and suggest potential clinical implications. Next, I present behavioral 
findings that suggest some non-reconsolidation based methods that go beyond standard 
exposure based therapies and could lead to enhanced fear regulation. I conclude by 
discussing future studies and the broader implications of this work. 
 
The effects of developmental stage and heritable background on CBT treatment 
outcomes 
 
While the studies presented in this manuscript suggest that developmental stage 
and genotypic variation play an important role in affecting fear regulatory capacity, there 
is also evidence that suggests these factors play a role in mediating treatment outcomes to 
exposure-based CBT.  
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Implications of developmental stage for treatment response to exposure-based 
therapy 
 
Given the converging evidence of diminished extinction learning during 
adolescence, it may follow that exposure-based forms of therapy may be less effective 
during this phase of development. The notion of an adolescent-specific diminished effect 
of exposure therapy was recently examined in existing clinical outcome data from a 
randomized placebo-controlled trial of children and adolescents with anxiety (Walkup et 
al., 2008; Drysdale et al., 2013). Specifically this study examined the effect of CBT 
compared to placebo on changes in anxiety symptoms after 12 weeks of CBT or placebo 
as a function of age. Figure 5.1.A below shows effect sizes of CBT relative to placebo 
separately for children and adolescents. The effect size for adults was estimated from 
outcome measures (improvement in anxiety symptoms) of a comparable adult clinical 
trial study comparing CBT vs. placebo (Davidson et al., 2004). These comparisons reveal 
a non-significant trend of diminished treatment efficacy for adolescents relative to either 
children or adults (Figure 5.2.A). A recent meta-analysis of 16 clinical studies (Bennett et 
al., 2013) shows a similar, but non-significant, dip in CBT efficacy for adolescents aged 
12 to 15 years compared to younger children and older adolescents  (Figure 5.1.B). 
Collectively, these data are concordant with pre-clinical data showing diminished 
extinction learning in adolescent mice and humans compared to adults and pre-
adolescents (Figure 5.2.A, B). Furthermore, these results provide preliminary evidence 
that diminished extinction learning mediated by age may be driving increased negative 
treatment effects of exposure-based CBT.  
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Figure 5.1. Developmental effects of CBT on anxiety symptoms. 
(A) Adolescents showed a trend toward diminished treatment effect size after CBT 
compared to preadolescents or adults in anxiety symptoms (Drysdale et al., 2013) (B) 
Results from a meta-analysis (Bennett et al., 2013) showed a non-significant trend for 
diminished treatment effects of CBT in adolescents aged 12 to 15 years as compared to 
younger and older individuals. Y-axis indicates magnitude. 
 
  
A. B. C. 
Figure 5.2.  Fear extinction learning and improvement of anxiety by age.  
(A) Adolescent (P29) mice show diminished extinction learning relative to adults (P70) 
and preadolescents (P23). (B) Human adolescents (mean age: 13.9 ± 1.47 years, n = 
25) show diminished fear extinction learning as indexed by skin conductance responses 
(SCR) compared with adults (mean age: 22.8 ± 2.57 years, n = 28) and children (mean 
age: 8.8 ±  1.78 years, n . 30). (C) A similar pattern emerges when the effect size of 
cognitive behavioral therapy (CBT) relative to placebo is calculated separately for 
children (CBT: children, mean age: 9.46 ± 1.36 years, n = 90; adolescents, mean age: 
14.34 ± 1.74 years, n = 49; placebo: children, mean age: 9.20 ± 1.31 years, n = 50; 
adolescents, mean age: 14.55 ± 1.64 years, n = 26) and adults. All results presented as 
mean ± SEM. ***p < .001 compared with other groups.  
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These studies suggest it may be important to consider the age of the individual 
when prescribing exposure-based treatment, but  don’t provide definitive support for such 
a claim. Across all the clinical trials reviewed, the forms of CBT used varied and often 
combined coping strategies and patient-focused activities with exposure.   To test the 
premise of age-dependent effects of exposure therapy based on principles of extinction, it 
would be necessary to test the effects of CBT specifically focused on exposure therapy 
rather than on the effects of CBT that rely more on coping strategies or a combination of 
coping and exposure-based approaches.  
 
Pre-clinical and clinical evidence suggests diminished fear regulatory capacity 
during the developmental stage of adolescence. Within the developmental and adult 
samples, however, there exists significant variability that   can’t   be   explained  by   age. In 
the next section, I discuss data suggesting genotypic variation as a factor that may 
account for some of this variability.   
 
Implications of genetic findings for treatment response to exposure-based therapy 
 
Pre-clinical data presented in Chapter 3 and described in Chapter 1, suggest 
genotypic variation in the genes FAAH and BDNF mediate fear extinction learning 
capacity. This data suggests that variation in these genes could be associated with 
treatment effects of exposure-based CBT.  There are not currently any published studies 
we are aware of that have examined the effect of genotypic variation in FAHH on 
response to exposure-based CBT. Converging evidence from animal and human studies 
points to diminished fear extinction learning for FAAH non A-allele carriers compared to 
the A-allele carriers (Chapter 3,  “Parallel effects of genetic variation in endocannabinoid 
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signaling on frontolimbic circuitry and function in adult humans”), suggesting that non A 
carriers would show less improvement after exposure based CBT compared to the A 
carriers, but this hypothesis has yet to be tested. Proof of concept for this approach has 
been supported, however, by a study of the effect of genotypic variation in BDNF on 
CBT treatment outcomes (Felmingham et al., 2013). In concordance with evidence that 
BDNF Met allele carriers show diminished fear extinction learning (Soliman et al 2010), 
this study demonstrated that exposure-based forms of CBT may be less effective for 
individuals with this genotype. Felmingham et al. (2013) examined the efficacy of CBT 
in adults with PTSD in an 8-week program of once-weekly 90-minute CBT sessions 
based on their genotype. Treatment response was assessed within 2 weeks of the 
cessation of treatment. BDNF Met allele carriers had poorer responses to exposure 
therapy than non-Met carriers (Figure 5.4). 
 
Figure 5.3.  Effect of BDNF genotype on response to CBT in PTSD patients. 
Met carriers showed less improvement after 8 weeks of CBT compared to non-Met 
carriers, as indexed by pre and post-treatment scores on the Clinician Administered 
PTSD Scale (from Felmingham et al., 2013).  
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Based on the preliminary data, it would be reasonable to hypothesize that, similar 
to BDNF, genotypic variation in FAAH might mediate exposure-based CBT effects in 
dose dependent fashion, with homozygous A-allele carriers showing more positive 
treatment outcomes than heterozygous A-allele carriers, and non A-allele carriers 
showing the least positive outcomes. There also exists the intriguing possibility of 
interactive and dose-dependent effects of genotypic variation in BDNF and FAHH on 
fear extinction learning. If the effects of variation in BDNF and FAAH on extinction 
learning interact in additive fashion, than the strongest extinction learning should be 
observed in homozygous A-allele FAAH/ non-met allele BDNF carriers, with the 
weakest extinction learning observed in the non-A-allele FAAH/homozygous met allele 
BDNF carriers. This idea is promising but has yet to be tested in a pre-clinical population 
or through genetic mutation studies in animals, which will be necessary before confident 
predictions can be made about interactive effects on exposure-based therapy outcomes. 
Studying the interactive effects of BDNF x FAAH on extinction learning is important as 
this work may one day set the stage for a diagnostic tool that predicts treatment outcomes 
more powerfully than either gene alone.    
 
Additional factors that could mediate individual differences in fear regulation 
 
Beyond genetic background and developmental history, other important 
individual difference factors have been associated with fear regulatory capacity and could 
play important roles in mediating the efficacy of exposure-based therapy: experiential 
history and sex.  
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Experiential factors impacting fear regulation 
 
Early life stress (ELS) such as abuse or neglect is associated with a high 
prevalence of later psychopathology and diminished emotion regulatory capacity (Green 
et al., 2010; Shonkoff et al., 2009).  One extreme example of early life stress is that of 
orphanage rearing, in which children are subjected to high stress and reduced child-parent 
interaction compared to their non-orphaned peers. Children reared in orphanages show 
higher incidence of psychopathology and emotion dysregulation compared to non-
orphans (Casey et al., 2005; Tottenham et al., 2010; Malter-Cohen et al., 2013 and Gee et 
al., 2013). However, it has been difficult to attribute these adverse outcomes directly to 
orphanage rearing because pre-existing conditions  (e.g., prenatal exposure to substances 
or genetic abnormalities) could not be ruled out. 
 
The effect of early life stress on emotion regulation and the underlying neural 
substrates was recently examined in parallel studies in humans and mice (Malter-Cohen 
et al., 2013). Mice allow for the control of environmental and genetic backgrounds that 
often confound naturalistic studies in humans.  Children (aged 5-11) performed an 
emotion regulation task as part of a functional imaging study.  The task was designed to 
assess response latency to approach recurrent neutral cues in anticipation of a rare threat 
cue (fearful face). Children reared in the orphanage were slower than non orphanage-
reared children to approach (detect) cues in the context of impending threat. This slower 
response latency was paralleled by greater fMRI BOLD amygdala activity in response to 
threat cues. In a parallel study, pre-adolescent mice were subjected to stress by means of 
limiting   nesting   material   available   to   the   dam,   while   the   control   group’s   rearing  
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environment was not disrupted. This manipulation led to the dam spending less time with 
her pups to mimic aspects of orphanage care. These mice were then tested post weaning 
in a task conceptually similar to the human task. In order to get the mice to approach 
potential threat, one of their favorite cocktails of sweetened condensed milk was used. 
The mice were trained to obtain the milk from a nozzle over several days in their home 
cage (i.e., approach a cue). On the last day the context was changed to a well-lit, odor-
barren novel cage, an environment of potential threat for rodents. Thus like the human, 
the mouse had to approach a cue (nozzle) in the face of potential threat (brightly lit, novel 
environment).  Early-life stress altered fear regulation in the postweaned mice, as 
measured by longer approach latencies to the nozzle in the novel cage. This behavioral 
pattern was mirrored by enhanced C-Fos activity in the amygdala to threat cues in pre-
adolescent mice, paralleling the human findings. 
 
How persistent are these changes?  Given that mice age more quickly than 
humans, the effects of early life stress in the mice were tracked into adulthood (i.e., 
postnatal day 70). Atypical behavior and brain activity persisted long after the stressor 
was removed and even with development of prefrontal regulatory regions.  These results 
are consistent with other animal studies that have shown chronic stress exposure mediates 
long-term amygdala reactivity and anxiety-like behavior in adulthood (Vyas et al., 2002).   
 
In an independent study of emotion regulation in children adopted from 
orphanages abroad, Gee and colleagues (2013) showed that children reared in orphanages 
have altered frontolimbic circuitry relative to nonadopted children. While this study did 
not directly test whether early life stress mediated changes in fear extinction learning per 
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se, it demonstrated heightened amygdala-driven reactivity to repeated presentations of 
empty threat. This pattern coupled with immaturity of prefrontal control regions and 
inputs may diminish emotion regulation and set the stage for long lasting emotion 
dysregulation.  
 
Together the developmental findings from rodent and human studies highlight 
how early life stress can lead to emotional dysregulation and altered connectivity of 
frontolimbic circuitry that may increase the risk for psychopathology.  Previous animal 
work examining the effects of early life stress (e.g. maternal deprivation) on long-term 
outcomes have shown altered social and fear behaviors and fronto-amygdala circuitry 
(Hofer, 1996; Romeo et al., 2003; Callaghan and Richardson, 2011). These findings are 
similar to these reports and have been extended by Gee and colleagues, (2013) who show 
a shift in the typical development of fronto-amygdala connectivity that is associated with 
anxiety-like behavior in orphanage-reared children. These findings suggest the 
importance of early interventions or rescue from early life stress to prevent atypical 
wiring of frontoamgydala circuitry that can lead to patterns of pathological fear 
responding.  Evidence in support of early intervention is provided by findings that 
children adopted within 12 to 24 months of age from the orphanage environment appear 
more resilient than those adopted later (Tottenham   et   al.,   2010;;   Rutter   and  O’Connor,  
2004; Rutter et al., 2010; Gunnar et al., 2000, 2007; Nelson et al., 2007). The clinical 
implications of these findings are that ELS could persistently diminish treatment response 
to exposure-based CBT all the way into adulthood. This suggests alternative methods of 
fear regulation characterized by diminished reliance upon prefrontal mechanisms 
(reconsolidation update) or enhanced frontoamygdala-mediated regulation of fear via 
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hippocampal contributions (as depicted in Figure 5.4) might be optimal for this 
population.  
 
 
 
Figure 5.4. Role of hippocampus in neural circuitry underlying fear extinction 
learning. During extinction of conditioned fear, hippocampal projections lead to 
excitation of IL (vmPFC in humans) and inhibition of BA neurons. Excitatory 
projections from IL innervate inhibitory ITC cells in the amygdala. Convergence of 
ITC, BA and LA inputs during extinction blocks output of CE neurons, blocking 
downstream CE output and blunting fear expression. (BA, basal amygdala; LA, lateral 
amygdala; ITC, intercalated cells; CE, central nucleus of amygdala; IL, infralimbic 
cortex; PL, prelimbic cortex). (Figure from Pattwell et al., 2013)   
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The impact of sex differences on fear extinction learning 
 
Studies have shown that females are at significantly higher risk for developing 
anxiety disorders than males (Kessler et al., 2005), and have demonstrated sex 
differences in neural regions associated with fear learning processes such as the 
amygdala, hippocampus and medial prefrontal regions (Goldstein 2001).  However, these 
data are not congruent with preclinical studies showing no effects of sex on extinction 
learning (Baran et al., 2009; Baran et al., 2010). These discordant findings have been at 
least partially explained by studies showing that sex-based differences in fear extinction 
are mediated by the phases of the estrous cycle in female rats and the menstrual cycle in 
women (Zeidan et al., 2011; Milad et al., 2009; Milad et al., 2010). That is, sex 
differences in these studies are not revealed in naturally cycling females, in either the 
rodents or the humans; they are only revealed when cycle phase is taken into 
consideration. In both rodents and humans, females with low estradiol showed 
diminished extinction retention compared to females with high endogenous estradiol and 
males (Milad et al., 2009; Milad et al., 2010). This suggests that sex hormones may 
influence fear regulatory capacity in women. The rat estrous cycle consists of five phases: 
the estrus, metestrus, diestrus, proestrus and estrus phases. Naturally cycling rodents 
demonstrated the most robust extinction recall when they underwent extinction during the 
proestrous cycle (Milad et al., 2009), during which levels of endogenous estrogen and 
progesterone are highest. This finding suggests that these sex hormones may be 
facilitating enhanced extinction learning in the female rodents (Milad et al., 2009). 
Similarly in humans, it has been shown that women with high estrogen exhibit 
significantly less post-extinction fear recovery compared to women with low estrogen. 
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The effect of facilitated extinction recall in women with high estrogen levels has been 
linked to increased vmPFC, hippocampal and amygdala activation during extinction 
recall, providing support for the notion that estrogen may be mediating extinction 
learning, potentially through enhanced consolidation (Zeidan et al., 2011).   
 
These findings carry some important clinical implications, particularly with 
regards to potential sex differences in response to exposure-based therapy. For one, 
exposure-based CBT might be differentially effective for any given woman in a time-
sensitive fashion, with treatment outcomes dependent on the specific phase of the 
menstrual cycle during which treatment occurs (both estrogen and progesterone levels are 
at their lowest levels during the early follic phase of the cycle, suggesting this may be a 
suboptimal time for exposure-based therapy). Furthermore, endogenous estradiol levels 
can decrease with the use of oral and intrauterine contraceptives, as well as during 
postpartum periods and menopause, during which times women show heightened risk for 
developing stress and anxiety disorders (Altshuler et al., 1998; Schnatz et al., 2010; 
Schmidt & Rubinow, 2009; Harsh et al., 2009). In summary, this data suggests that 
timing exposure-based therapy to the menstrual cycle might be necessary to optimize 
treatment outcomes for women, whereas alternative therapeutic approaches might be 
considered  when  timing  changes  aren’t possible.   
 
Reconsolidation update of fear memory: limitations and promises 
 
The factors described above – genotypic variation, developmental stage, 
experiential history and sex – may explain some of the variability observed in response to 
exposure-based treatments for individuals with anxiety and stress disorders (Walkup et 
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al., 2008), and could help clinicians identify individuals who might not respond well to 
exposure-based therapies.  Preclinical data suggests that an approach based on the 
principles   of   memory   reconsolidation   (Chapter   4,   “Extinction during memory 
reconsolidation blocks recovery of fear in adolescents”)  offers  a  promising  alternative  for  
altering or regulating fear that bypasses prefrontal regulation and could set the stage for 
new treatments for such individuals. In this next section, I discuss some divergent results 
across fear memory reconsolidation studies in humans and touch on potential limitations 
and challenges in translating the pre-clinical findings into new therapeutic approaches. 
This is followed by a discussion of alternatives to reconsolidation or exposure-based 
methods of fear regulation.  
 
Methodological factors that could mediate or block the reconsolidation update effect 
and clinical implications 
 
While several studies have demonstrated that extinction during reconsolidation 
attenuates conditioned fear in humans (Schiller et al., 2010a; Schiller et al., 2013; Agren 
et al., 2012; Oyarzun et al., 2012; Steinfurth et al., 2014; Liu et al., 2014), some studies 
have failed to replicate these results (Soeter & Kindt 2011; Kindt & Soeter 2013; Golkar 
et al., 2012). Methodological differences across these studies are numerous and likely 
play a role in these differing results. Evidence suggests that the following factors could 
play important roles in rendering the behavioral manipulation less effective or preventing 
reconsolidation from being induced at all: (1) the use of fear-relevant compared to fear-
irrelevant pictures as conditioned stimuli, (2) online self report of anticipatory fear, (3) 
acquisition strength, and (4) the age of the conditioned fear memory.  As these factors 
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represent potential boundary conditions on the reconsolidation update effect, it is 
important to consider how they might impact efforts to target reconsolidation of traumatic 
memory as a potential treatment for psychopathology.  
 
Fear-relevant vs fear-irrelevant conditioned stimuli 
 
In three of the non-replications of fear memory reconsolidation update (Soeter & 
Kindt 2011; Kindt & Soeter 2013; Golkar et al., 2012), fear-relevant pictures were used 
as conditioned stimuli instead of neutral stimuli, such as geometric shapes (Schiller et al., 
2010a; Schiller et al., 2013; Johnson & Casey, 2015b). The classification of a given 
stimuli  as  “fear-relevant” is based on an evolutionary perspective that suggests our fears 
of certain objects, such as snakes, spiders, or angry human faces, are innate because they 
represented threat to the survival of our ancestors. By this account, responses to fear 
relevant stimuli may be qualitatively distinct from responses evoked by fear irrelevant 
stimuli, such as guns, motorcycles and automobiles (or neutral stimuli such as geometric 
shapes). Fear relevant stimuli may generate enhanced conditioning compared to fear 
irrelevant stimuli (Ohman & Mineka 2001), and are particularly resistant to extinction 
compared to neutral stimuli (Mineka & Ohman 2002), such as the colored squares used in 
Schiller et al. (2010a) and Johnson & Casey (2015b). This is an important 
methodological distinction and suggests the important clinical consideration that phobias 
based on innately feared objects might not be amenable to treatment via a reconsolidation 
update-based clinical approach. Shiban et al. (2015) tested reconsolidation-augmented 
exposure therapy on a clinical sample of spider phobics and showed no effect of 
reactivation of fear memory prior to exposure therapy. As suggested, one possible 
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explanation for these negative results is that phobias with fear-relevant stimuli at their 
core are not entirely built on associative learning processes and may be based on 
representations qualitatively distinct from the type of associative fear memories encoded 
in Pavlovian conditioning studies using neutral images as conditioned stimuli.  
 
Online self-report of anticipatory fear 
 
Kindt & Soeter (2013) and Soeter & Kindt (2011) failed to replicate the finding 
that the return of fear was prevented when extinction occurred during reconsolidation. In 
these studies, participants made online ratings of distress and US expectancy, 
respectively. The continuous evaluation of the experimental contingencies forced the 
participants to direct attention towards, and may have strengthened their conscious 
knowledge of, the CS-US relationship. This behavior may have altered the neural 
substrates mediating the learning (Funayama et al., 2001; Coppens et al., 2009) by 
recruiting higher cortical brain regions involved in declarative knowledge (Weike et al., 
2007) and driving amygdala-based fear responses through top-down mechanisms even if 
the original association had been disrupted at the level of the amygdala during 
reconsolidation. In a clinical context, standard exposure-based CBT protocols often 
dictate that patients self-report their fear levels during the exposure session (S. Bennett, 
personal communication, November 15, 2014). While this may be viewed as an 
important means by which to gauge the within-session effectiveness of the therapy, its 
possible that this process could change the nature of the fear memory, shifting the neural 
substrate from a primarily subcortical to a more cortical representation and making the 
memory less amenable to attenuation via reconsolidation update.  
81  
Acquisition memory strength 
 
There are wide discrepancies across studies in reinforcement rates used during 
fear acquisition. Soeter and Kindt (2011), and Kindt and Soeter (2013) used 100% and 
75% reinforcement on CS+ trials during acquisition (and demonstrated no effect of 
reconsolidation update), while studies by Schiller et al., (2010a), Oyarzun et al., (2012) 
and Johnson & Casey (2015b) employed 37.5%, 37.5% and 50%, respectively. It has 
been suggested that the lack of disruption of reconsolidation in Soeter and Kindt (2011) 
and Kindt and Soeter (2013) might be attributed to stronger conditioning creating a more 
potent fear memory that proved resistant to reconsolidation update (Oyarzun et al., 2012; 
Golkar et al., 2012). However, recent findings by Agren et al. (2012) have shown 
persistent attenuation of fear memory utilizing a reactivation – extinction procedure with 
100% reinforcement during acquisition, suggesting reconsolidation update can still occur 
with continuous reinforcement.   
 
Some evidence does suggest memory strength may be an important factor in 
whether or not reconsolidation can be induced. Wang et al., (2009) manipulated fear 
acquisition strength by varying the number of reinforcement trials, with mice in the 
strong learning condition receiving 10 tone-shock trials and those in the weak learning 
condition receiving just 1 trial. While mice in the weak training group showed no return 
of fear after post-reactivation administration of anisomycin, mice in the strong training 
group showed significantly more freezing at the end of the extinction session and strong 
return of fear after reconsolidation interference. Wang et al. (2009) suggests that 
increasing reinforcement trials during acquisition down regulates mechanisms in the 
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lateral basal amygdala upon which reconsolidation is dependent and prevents 
pharmacological disruption of a fear memory during reconsolidation from occurring.  In 
clinical terms, this represents a significant issue as it would suggest the possibility that 
strong trauma memories, such as those that often set the stage for stress and anxiety 
disorders such as PTSD, may be resistant to undergoing reconsolidation, which would 
potentially negate reconsolidation as a therapeutic target. 
 
  One challenge in interpreting the results of human fear learning studies in the 
context of real-life trauma is that, due to ethical concerns, the intensity of the US is 
relatively mild and “annoying   but not painful”   (Johnson and Casey, 2015b), which 
minimizes its aversive nature. Most human studies are required to push the aversiveness 
of the US up to this ethical ceiling in order to get sufficient fear acquisition at all, let 
alone different levels of acquisition strength. As such, it’s difficult to know whether the 
strength of fear acquisition typically seen in human studies constitutes   “weak”   or  
“strong”  learning  relative  to  the  rodent  studies. Breaching this ethical ceiling is neither a 
realistic nor desirable option.  Therefore, we are largely dependent, for the time being, 
upon rodent studies to explore questions regarding the effects of acquisition memory 
strength on reconsolidation processes.  This highlights an important feature of a 
translational (animal to human) approach to understanding fear learning processes. Due 
to the strong evolutionary and cross-species conservation of fear learning processes and 
associated neural substrates, questions that are not conducive to exploration in the human 
species can often be usefully probed in the rodent.  
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Age of the conditioned fear memory 
 
The age of a fear memory may also be an important factor in mediating 
reconsolidation processes. While Wang et al. (2009) showed a return of fear after 
reconsolidation  interference  in  the  “strong  training”  rodents,  this  condition  was  transient.  
When a strong memory was reactivated just 7 days after training, post-reactivation 
infusion of anisomycin did not disrupt the fear memory, whereas the same procedure 
conducted 30 or 60 days after training led to attenuation of the fear memory. This would 
suggest that a strong fear memory might be resistant to reconsolidation update during an 
early transient window after which the fear association is transformed and 
reconsolidation interference becomes possible. Steinfurth et al (2014) have demonstrated 
in adult humans that, similar to young memories (one day old), older fear memories 
(seven days old) can be altered through extinction training during memory 
reconsolidation.  While this finding is consistent with rodent studies that have shown 
older memories could be altered during reconsolidation using a pharmacological 
approach (Nader et al., 2000; Debiec et al., 2002), it is not congruent with a behavioral 
study in mice that showed return of fear after extinction during reconsolidation of a 7-day 
old memory (Clem & Huganir, 2010). One possible explanation for these divergent 
results is cross-species differences in life expectancy, as 7 days in mice is roughly 
equivalent to 70 days in humans (Quinn 2005). Future studies that test whether longer-
term fear memories, similar to acute fear memories, are amenable to reconsolidation 
update in humans will shed light on this issue.  
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This preclinical research highlights many potential factors that could prevent 
reconsolidation interference from occurring, suggesting potential challenges for both 
future basic research and development and implementation of therapeutic applications 
based on the principles of fear memory reconsolidation. Certain types of fear memories, 
such as those involving the kinds of fear-relevant stimuli that often characterize certain 
phobias, may be resistant to reconsolidation update. Self-report of fear during exposure 
therapy might change the neural representation of a fear memory, preventing it from 
being altered during reconsolidation.  Finally, in a clinical setting, the issues of strength 
and age of a fear or trauma memory are important because patients presenting with 
anxiety and stress disorders have often experienced extremely aversive past events, one 
or multiple times, that may have occurred anywhere from days to months to years in the 
past. Relatively few studies have tested the impact of these factors on reconsolidation 
update in humans. Future work that tests the temporal boundaries of reconsolidation, as 
well as whether memory strength presents a boundary condition on reconsolidation 
update, will be useful in determining when and under what conditions a reconsolidation 
update-augmented therapeutic approach may be appropriate. Despite these challenges, 
reconsolidation augmented approaches to treating fear-related disorder holds significant 
promise and efforts are underway to test reconsolidation-augmented clinical protocols 
(Shiban et al., 2015). Although outside the realm of fear learning, Xue et al (2012) has 
provided an instructive example of research based on the principles of memory 
reconsolidation that begins to bridge the gap between the lab and the clinic. In a series of 
rodent and human studies, they utilized a memory reactivation – extinction procedure to 
decrease drug effects and drug seeking in a rat model of relapse, and reduce drug 
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cravings for in-patient heroin addicts. Multiple clinical trials testing reconsolidation-
augmented therapies are underway, including studies in which reconsolidation has been 
targeted to reduce fear of flying for patients with flying phobias and treat anxiety 
disorders, as well as to test novel interventions for cocaine and nicotine dependence 
(https://clinicaltrials.gov/ct2/results?term=reconsolidation&Search=Search. Accessed 
January 12, 2015).  
 
Other promising non-pharmacological approaches to augmenting extinction 
 
Cognitive forms of fear regulation 
 
While the efficacy of exposure-based CBT depends on the ability of a given 
individual to acquire and retrieve extinction memories (Berry et al., 2009), cognitive 
strategies can also be employed to regulate conditioned fear responding. Standard CBT 
protocols generally include a cognitive component in which patients are directed to 
strategically reframe anxiety-provoking situations in order to reduce the negative 
emotional responses that these situations elicit (Beck & Emery 1985). One form of 
cognitive regulation is emotional reappraisal, in which an automatic emotional response 
to an emotional event is controlled through conscious transformation of its meaning 
(Gross 2001). Human fMRI studies have shown that successful reappraisal of negatively 
valenced stimuli is dependent upon recruitment of prefrontal and cingulate regions 
associated with cognitive control (Ochsner et al., 2004). However, the prefrontal cortex is 
still maturing into early adulthood, suggesting that children and adolescents might show 
diminished reappraisal capacity compared to adults. Recent studies have presented some 
evidence to this effect, with reappraisal success positively correlating with age across 
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adolescence (Silvers et al., 2012; McCrae et al., 2012). Although only a small number of 
studies have examined the effects of developmental and individual differences on 
reappraisal of threat, future pre-clinical research that tests the effect of age, genes, sex 
and experiential history on different forms of reappraisal across childhood and 
adolescence will help shed light on which reappraisal strategies might be most effective 
at any given individual. 
 
Attentional Control 
 
Another important cognitive factor mediating fear regulation is attentional 
control. The ability to increase attention to threat stimuli is an adaptive function that 
facilitates the detection of danger (LeDoux 2000). However, devoting an inappropriate 
amount of attentional resources to non-significant or low-level threats can be 
maladaptive. This notion is supported by research providing strong evidence for a 
positive correlation between threat related attentional bias and anxiety (Bar-Haim et al., 
2007; Mathews and MacLeod, 1985; Monk et al., 2008). Emerging data suggests that 
reductions in attentional threat bias can be achieved through attentional bias modification 
therapy (Hakamata et al., 2010; Bar-Haim, 2010; MacLeod and Mathews, 2012), which 
involves teaching individuals to shift attention away from threat-related stimuli through 
repetitive, computer-based training (MacLeod and Mathews, 2012). While attentional 
bias modification therapy has been shown to lead to decreases in threat bias as well as 
diminished anxiety symptoms  (Hakamata et al., 2010), treatment outcomes across 
studies are inconsistent (Mogoase et al., 2014), suggesting further research will be 
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necessary in order to optimize these techniques and determine when, and for whom, 
attention-based therapy will be most beneficial.    
 
Safety Signal Learning 
 
Emerging evidence suggests that adaptive regulation of fear is not only dependent 
on successful extinction of conditioned fear, but also upon safety signal learning (i.e. 
conditioned inhibition); that is, the ability to utilize the presence of a safety cue to 
transfer inhibition to the aversive cue (Rescorla 1969; Jovanovich et al., 2012). In the lab, 
safety signal learning (i.e. conditioned inhibition) is typically assessed by training 
participants to pair one cue with an aversive event and another cue with the absence of 
the aversive event. These two cues are subsequently paired to test if participants utilize 
the presence of the safety cue to inhibit fear responses to the fear cue.  Research 
exploring safety learning processes have been gaining interest, as studies have shown 
evidence of diminished safety learning ability in individuals with PTSD compared to 
control subjects (Jovanovich et al., 2009, 2010a, 2010b, 2012).  
 
Data suggests distinct underlying neural mechanisms for safety signal learning 
compared to fear extinction learning. As described in detail in Chapter 1, the neural 
mechanisms of cued fear extinction learning consist of projections from the IL prefrontal 
cortex (mouse) / subgenual (human) vmPFC to the amygdala, with contextual fear 
regulation mediated via projections from the hippocampus to the amygdala and mPFC. 
While the circuitry associated with safety signal learning has been less well 
characterized, and much of the research record shows contrasting results, collective 
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evidence suggests important roles for the medial prefrontal cortex, hippocampus, striatum 
and insula.   
 
While some studies have shown lesions or pharmacological inhibition of the 
vmPFC in rodents had no effect on the safety signal, suggesting safety signal learning 
may occur independent of vmPFC activation (Gewirtz et al., 1997; Christianson et al., 
2008), multiple studies have shown increased activity in the vmPFC in response to cues 
that signal positive compared to negative outcomes (Delgado et al., 2006; Kalisch et al., 
2006; Milad et al., 2007; Mobbs et al., 2010; Phelps et al., 2004; Quirk et al., 2006; 
Schiller et al., 2008). Furthermore, Likhtik et al. (2014) have shown increased synchrony 
between mPFC and the basal lateral amygdala (BLA) for both safe and aversive cues in 
the theta frequency (4-12 Hz) in animals who successfully discriminated between these 
cues (as indexed by freezing) compared to those who showed fear generalization. Thus, 
collective evidence suggests a strong role for the prefrontal cortex in safety signal 
learning.   
 
Early theorists proposed that the hippocampus is essential for safety signal 
learning (i.e. behavioral inhibition; Douglas et al., 1967; Kimble et al., 1969), but 
subsequent research has provided mixed results.  Chan et al. (2001) showed that the 
hippocampus was involved in retention and retrieval of safety signal but not its 
acquisition, while Kazama et al. (2010) conducted a hippocampal lesion study in adult 
non-human primates, showing that the hippocampus is not necessary for either safety 
signal learning or the blunted fear expression observed during the safety transfer test. It 
has also been suggested that safety signals may themselves constitute a form of reward. 
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Evidence indicates that responses in the striatum, a neural region associated with 
encoding reward value, were increased with safety conditioning and decreased with fear 
conditioning  (Rogan et al., 2005).  Further support for this notion is provided by a rodent 
study showing a large proportion of neurons in the basal lateral amygdala that respond to 
a CS- also are active in response to a CS predictive of reward, suggestive that safety and 
reward learning rely on overlapping cell populations in the amygdala (Sangha et al., 
2013).  Another structure that may play a central role in safety signaling is the posterior 
insular cortex (IC), which acts as a way station for sensory input, with direct projections 
to the amygdala (Nieuwenhuys, 2012). Evidence from lesion studies showed that 
permanently or temporarily inactivating the IC (Christianson et al., 2008, 2011) 
eliminated the stress-buffering effects of the safety signal. This is in concordance with 
data showing functional and structural abnormalities in IC in anxiety and PTSD (Paulus 
and Stein, 2006; Hughes and Shin, 2011).  
 
While the neural mechanism(s) underlying safety learning are not well 
understood, the data outlines a neural circuit both partially overlapping yet qualitatively 
distinct from that associated with extinction learning, and highlights its importance as a 
unique and important diagnostic and therapeutic target. Among the diagnostic 
possibilities include the possibility that diminished or abolished safety signal learning 
could represent a risk factor for the development of fear-related disorders, such as PTSD 
(pre-trauma), or if assessed in the aftermath of trauma, could be predictive of who might 
develop pathological conditions (Javancovic et al., 2012).  
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A comprehensive discussion of alternative behavioral methods that could lead to 
enhanced fear regulation is beyond the scope of this manuscript. However, it should be 
noted that, similar to exposure-based therapies, clinical treatments based on emotional 
reappraisal, attentional control or safety learning approaches may be more effective for 
some individuals than others. It is important that future research identifies factors that 
mediate  any  given  individual’s  capacity  to  successfully  employ  such strategies to regulate 
fear.  Identifying these factors may suggest a personalized combination of therapies 
customized to the individual to maximize positive treatment outcomes.  
 
Future Studies  
 
This manuscript has presented pre-clinical research identifying factors associated 
with developmental and individual difference in the capacity to regulate fear, and also 
described a method based on the principles of memory reconsolidation that led to 
enhanced fear regulation. Clinical relevance has been a guiding principle of this work, 
and, as such, it is hoped that these studies represent a foundation upon which new or 
augmented clinical approaches to treating anxiety and stress disorders might be built. 
Below, I describe three current projects, designed to bridge important translational gaps 
and build on the work presented in Chapters 2 through 4.  
 
Direct assessment of the relationship between fear extinction learning and CBT 
treatment outcomes in a clinical anxiety population 
 
Chapter  2  (“Altered fear learning across development in humans”)  described that 
diminished extinction learning has been observed in both adolescent humans and mice 
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while evidence presented earlier in this chapter showed a trend for diminished treatment 
effects of CBT during this developmental stage (Figure 5.1). While this these data are 
suggestive of a relationship between extinction learning capacity and CBT treatment 
outcomes (Figure 5.2), direct within-subject evidence would provide crucial support for 
this link. In collaboration with a pediatric anxiety clinic, we are currently testing children 
and adolescent anxiety patients in a study that will assess   the   patients’ fear regulatory 
capacity utilizing a Pavlovian fear conditioning and extinction paradigm in a controlled, 
experimental setting. This will be followed by 8 weeks of CBT treatment for these same 
patients, allowing us to directly compare the   patients’ extinction learning in the 
experimental setting with their treatment outcomes. We hypothesize that the data will 
show a positive correlation between extinction learning and treatment outcomes from 
CBT. This would provide strong evidence for diminished fear extinction learning as a 
mechanism underlying the diminished responses to exposure-based therapy previously 
observed during adolescence and would further highlight the need to develop alternatives 
to exposure-based therapies for this developmental group.  
 
Probing the effect of genotypic variation in FAAH (and interactions with BDNF) on 
CBT treatment outcomes 
 
Chapter 3 (“Identical genetic variation in mouse and human FAAH enhances 
extinction learning and frontoamygdala connectivity”)  presented  evidence  that  genotypic 
variation in FAAH can mediate fear extinction learning. This suggests that FAAH might 
impact treatment outcomes from CBT, similar to that shown for BNDF by Felmingham et 
al. (2013). Plans are currently underway to test the prediction of improved CBT outcomes 
92  
for A-allele carriers compared to non A-allele carriers, potentially setting the stage for 
genotypic variation in FAAH to be used as a biomarker for response to exposure-based 
CBT. Furthermore, genotypic variability in FAAH and BDNF may interact to mediate 
fear extinction learning, leading to enhanced fear regulation when both favorable variants 
are present compared to either one alone. If future pre-clinical data supports this 
hypothesis, this would suggest that the BDNF x FAHH interaction might act as a potent 
biomarker for treatment outcomes from CBT.   
 
Developing and testing a reconsolidation-update augmented clinical therapy 
protocol for treatment of clinical patients with PTSD 
 
Chapter 4 (“Extinction during memory reconsolidation blocks recovery of fear in 
adolescents”) presented data suggesting an alternative approach to fear regulation is 
possible based on the principles of memory reconsolidation, largely bypassing prefrontal 
regulation of fear, making it ideal for special populations who show diminished capacity 
for prefrontally-mediated fear regulation. This project plans to implement and conduct a 
preliminary investigation of a reconsolidation update-enhanced exposure therapy for the 
treatment of PTSD in military personnel. The study would attempt to fill a translational 
gap between preclinical findings and clinical practice by first testing the effectiveness of 
reconsolidation update in PTSD subjects in a controlled, experimental study, and, second, 
by establishing and testing a clinical protocol of reconsolidation update-enhanced 
exposure therapy with the goal of reducing PTSD symptoms and setting the stage for a 
large scale clinical trial. This study will also include age and genetic factors to allow for 
the testing of the effectiveness of reconsolidation update-enhanced exposure therapy on 
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the patient populations that would potentially benefit the most from this treatment 
regimen. 
 
Conclusions 
  
The preliminary data presented here suggest diagnostic criteria by which to 
identify individuals with fear-related disorders who may not respond well to exposure-
based therapy by age (adolescence) and genotype (BDNF and possibly FAAH), as well as 
describing two additional factors that could play an important role in treatment outcomes, 
sex and experiential history. These findings identify factors that could serve as predictive 
markers of response to clinical treatment. These markers could potentially be used to help 
guide clinicians in identifying patients for whom more efficacious treatment approaches 
(such as reconsolidation-augmented exposure therapy) might be necessary and may 
contribute to efforts to build a personalized approach to treating psychiatric disorders 
built on the core premise that individual differences should play a major role in tailoring 
the therapeutic approach (Figure 5.5).   
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While the pre-clinical findings presented here are promising, the perhaps even 
tougher road is still ahead, which is to translate these findings into efficacious clinical 
therapies. Translating experimental research into effective clinical treatment has 
historically been a slow process, as is exemplified by the case of cognitive behavioral 
Figure 5.5. An individually tailored approach to treating anxiety and stress 
disorders. The top level of this schematic depicts factors that mediate fear regulatory 
capacity: genetic background, developmental stage, experiential history and sex.       
N-dimensional interactions between these factors will mediate the specific point at 
which any given individual falls along the phenotypic continuum. Assessing these 
factors may allow a mental health professional to predict whether a patient may or may 
not respond well to exposure-based therapy. This would allow for a personalized 
therapeutic approach targeted to the individual.   
*Loss-of-function mutation** Gain-of-function mutation    
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therapy.  An empirically validated and undeniably successful behavioral treatment for 
fear-related disorders, exposure-based CBT is based on the general principles of classical 
conditioning and associative learning, originally discovered in the early 20th century by 
Watson and Rayner (1920), Pavlov (1927) and others. But these ideas had little impact on 
clinical practice during their own time, as psychiatrists were influenced almost 
exclusively by   Freudian   psychoanalysis.   It   wasn’t   until   the   early   1960s   that   therapies  
built on principles of associative learning emerged and overcame Freudian techniques, 
through the systematic application of basic learning principles discovered by Wolpe 
(1958) and the research and advocacy of Eysenck (1952, 1960), among others. In the 
decades since, clinical therapies have been continually refined by new pre-clinical 
findings provided during the cognitive revolution of the 1970s and 80s (Beck, 1985) and 
the rise of affective neuroscience research, and technologies such as fMRI, during the 
1990s and 2000s (Phelps et al., 2004; Milad and Quirk, 2012). The fear domain has 
provided a potent example of the power of translational research, as basic animal and 
human research programs and findings from the fields of genetics, molecular biology, 
pharmacology, psychiatry and clinical psychology have mutually contributed to 
exponentially and rapidly increasing our understanding of fear-related behaviors and 
disorders, across molecular, genetic, circuit and behavioral levels.  
 
One of the primary modern challenges to the goal of improving treatment of 
psychiatric disorders is derived from the high variability observed across individuals in 
response to treatment.  A homogenous approach to treating pathological conditions such 
as anxiety and stress disorder is bound to be suboptimal for many patients. As the 
96  
application of learning theory once set the stage for a new and more effective therapeutic 
approach to treating pathological fear, delineating the individual and developmental 
differences that impact fear regulation may do the same, leading to identification of 
patients who may not respond well to standard clinical protocols and who may require a 
personalized treatment approach (i.e. precision medicine). This approach has been 
promoted by President Obama, who recently announced (and requested significant 
financial support for) the Precision Medicine Initiative, a government sponsored 
enterprise that proposes to   “pioneer   a   new   model   of   patient-powered research that 
promises to accelerate biomedical discoveries and provide clinicians with new tools, 
knowledge, and therapies to select which treatments will work best for which patients 
(NIH, 2015).” This announcement suggests broad support for a move away from viewing 
victims of disease as members of a homogenous group and towards a future in which 
treatment of individuals might become the norm.  The studies presented in this 
manuscript represent a small contribution to the growing effort to build the body of 
scientific evidence necessary to move precision medicine from concept to reality.   
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